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A B S T R A C T
Background
Being diagnosed with human immunodeficiency virus (HIV), and labelled with a chronic, life-threatening, and often stigmatizing
disease, can impact on a person’s well-being. Psychosocial group interventions aim to improve life-functioning and coping as individuals
adjust to the diagnosis.
Objectives
To examine the effectiveness of psychosocial group interventions for improving the psychological well-being of adults living with HIV/
AIDS.
Search methods
We searched the following electronic databases up to 14March 2016: the Cochrane Central Register of Controlled Trials (CENTRAL)
published in the Cochrane Library (Issue 2, 2016), PubMed (MEDLINE) (1996 to 14 March 2016), Embase (1996 to 14 March
2016), and Clinical Trials.gov.
Selection criteria
Randomized controlled trials (RCTs) or quasi-RCTs that compared psychosocial group interventions with versus control (standard care
or brief educational interventions), with at least three months follow-up post-intervention. We included trials that reported measures
of depression, anxiety, stress, or coping using standardized scales.
Data collection and analysis
Two review authors independently screened abstracts, applied the inclusion criteria, and extracted data. We compared continuous
outcomes using mean differences (MD) with 95% confidence intervals (95% CIs), and pooled data using a random-effects model.
When the included trials used different measurement scales, we pooled data using standardized mean difference (SMD) values. We
reported trials that we could not include in the meta analysis narratively in the text. We assessed the certainty of the evidence using the
GRADE approach.
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Main results
We included 16 trials (19 articles) that enrolled 2520 adults living with HIV. All the interventions were multifaceted and included a
mix of psychotherapy, relaxation, group support, and education. The included trials were conducted in the USA (12 trials), Canada
(one trial), Switzerland (one trial), Uganda (one trial), and South Africa (one trial), and published between 1996 and 2016. Ten trials
recruited men and women, four trials recruited homosexual men, and two trials recruited women only. Interventions were conducted
with groups of four to 15 people, for 90 to 135 minutes, every week for up to 12 weeks. All interventions were conducted face-to-face
except two, which were delivered by telephone. All were delivered by graduate or postgraduate trained health, psychology, or social care
professionals except one that used a lay community health worker and two that used trained mindfulness practitioners.
Group-based psychosocial interventions based on cognitive behavioural therapy (CBT)mayhave a small effect onmeasures of depression,
and this effect may last for up to 15 months after participation in the group sessions (SMD −0.26, 95% CI −0.42 to −0.10; 1139
participants, 10 trials, low certainty evidence). Most trials used the BeckDepression Inventory (BDI), which has a maximum score of 63,
and the mean score in the intervention groups was around 1.4 points lower at the end of follow-up. This small benefit was consistent
across five trials where participants had a mean depression score in the normal range at baseline, but trials where the mean score was in
the depression range at baseline effects were less consistent. Fewer trials reported measures of anxiety, where there may be little or no
effect (four trials, 471 participants, low certainty evidence), stress, where there may be little or no effect (five trials, 507 participants, low
certainty evidence), and coping (five trials, 697 participants, low certainty evidence).
Group-based interventions based on mindfulness have not demonstrated effects on measures of depression (SMD −0.23, 95% CI
−0.49 to 0.03; 233 participants, 2 trials, very low certainty evidence), anxiety (SMD −0.16, 95% CI −0.47 to 0.15; 62 participants, 2
trials, very low certainty evidence), or stress (MD −2.02, 95% CI −4.23 to 0.19; 137 participants, 2 trials, very low certainty evidence).
No mindfulness based interventions included in the studies had any valid measurements of coping.
Authors’ conclusions
Group-based psychosocial interventions may have a small effect on measures of depression, but the clinical importance of this is unclear.
More high quality evidence is needed to assess whether group psychosocial intervention improve psychological well-being in HIV
positive adults.
P L A I N L A N G U A G E S U M M A R Y
Does group therapy improve well-being in people living with HIV?
Cochrane researchers conducted a review of the effects of group therapy for people living with human immunodeficiency virus (HIV).
After searching for relevant trials up to 14 March 2016, they included 16 trials reported in 19 articles that enrolled 2520 adults living
with HIV. The included trials were conducted in the USA (12 trials), Canada (one trial), Switzerland (one trial), Uganda (one trial), and
South Africa (one trial), and published between 1996 and 2016. Ten trials recruited men and women, four trials recruited homosexual
men, and two trials recruited women only.
What is group therapy and how might if benefit people with HIV?
Group therapy aims to improve the well-being of individuals by delivering psychological therapy in a group format, which can encourage
the development of peer support and social networks. Group therapy often also incorporates training in relaxation techniques and
coping skills, and education on the illness and its management.
Human immunodeficiency virus (HIV) causes a chronic, life threatening, and often stigmatising disease, which can impact on a person’s
well-being. Group therapy could help people living with HIV to adapt to knowing they have HIV, or recover from depression, anxiety,
and stress.
What the research says
Group-based therapy based on cognitive behavioural therapy may have a small effect on measures of depression, and this effect may
last for up to 15 months after participation in the group sessions (low certainty evidence). This effect was apparent in groups who did
not appear to be depressed on clinical scoring systems before the therapy started. The research also showed there may be little or no
effect on measures of anxiety, stress, and coping (low certainty evidence).
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Group-based interventions based on mindfulness have been studied in two small trials, and have not demonstrated effects on measures
of depression, anxiety or stress (all very low certainty evidence). No mindfulness based interventions included in the studies had any
valid measurements of coping.
Overall, the review suggests that existing interventions have little to no effect in increasing psychological adjustment to living with
HIV. More good quality studies are required to inform good practice and evidence.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Group therapy (cognitive behavioural therapy (CBT)) versus control for improving psychological well-being in adults living with HIV
Patient or population: adults living with HIV
Settings: any sett ing
Intervention: group therapy based on CBT
Outcomes Illustrative comparative risks (95% CI)* Number of participants (tri-
als)
Certainty of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Control Group therapy (CBT)
Depression score
Follow-up: 6 to 15 months
The mean scores in the con-
trol groups at the end of fol-
low-up ranged f rom normal
to moderately depressed
The mean score in the inter-
vent ion groups was:
0.26 standard deviations
(SDs) lower
(0.42 lower to 0.10 lower)
1139
(10 trials)
⊕⊕©©
low1,2,3,4
due to indirectness and risk
of bias
There may be a small bene-
f it which lasts for up to 15
months
Anxiety score
Follow-up: 6 to 15 months
The mean scores in the con-
trol groups at the end of fol-
low-up ranged f rom normal
to clinically anxious
The mean score in the inter-
vent ion groups was:
0.12 SDs lower
(0.31 lower to 0.06 higher)
471
(4 trials)
⊕⊕©©
low2,5,6,7
due to indirectness and risk
of bias
There may be lit t le or no ef -
fect on mean anxiety scores
Stress score
Follow-up: 6 to 15 months
The mean score in the con-
trol groups at the end of fol-
low-up were variable
The mean score in the inter-
vent ion groups was
0.04 SDs lower
(0.23 lower to 0.15 higher)
507
(5 trials)
⊕⊕©©
low2,5,6,7
due to indirectness and risk
of bias
There may be lit t le or no ef -
fect on mean stress scores
Coping score
Follow-up: 6 to 15 months
The mean score in the con-
trol groups at the end of fol-
low-up were variable
The mean score in the inter-
vent ion groups was
0.04 SDs higher
(0.11 lower to 0.19 higher)
697
(5 trials)
⊕⊕©©
low2,5,6,7
due to indirectness and risk
of bias
There may be lit t le or no ef -
fect on mean coping scores
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Studies used a variety of dif f erent scales to measure depression, anxiety and stress. Consequent ly, trials were pooled using a standardized mean dif ference. Examples of how
large this ef fect would be on standardized measurement scales are given in the review main text and abstract.
Abbreviations: CBT: cognit ive behavioural therapy; CI: conf idence interval; SD: standard deviat ion
GRADE Working Group grades of evidence
High certainty: f urther research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate certainty: f urther research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low certainty: f urther research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low certainty: we are very uncertain about the est imate.
1Downgraded by 1 for serious risk of bias: most of the trials did not adequately described a method of allocat ion concealment,
and so trials are at unclear or high risk of select ion bias. Loss of follow-up was generally more than 20% and attrit ion bias
may be present.
2No serious inconsistency: stat ist ical heterogeneity between trials was low.
3Downgraded by 1 for serious indirectness: most trials were f rom high-income sett ings (USA, Canada, and Switzerland), and
in f ive trials the mean depression score at baseline was in the normal (not depressed) range. Only f ive trials evaluated groups
with measurable levels of depression and in these trials the ef fects were inconsistent.
4No serious imprecision: the ef fect is small but stat ist ically signif icant. The clinical signif icance is unclear.
5Downgraded by 1 for serious risk of bias: most of the trials did not adequately described methods to prevent select ion bias.
6Downgraded by 1 for serious indirectness: although ef fects were not seen in these few trials, we cannot exclude the
possibility of ef fects in some populat ions.
7No serious imprecision: the ef fect size is close to zero with a narrow 95% CI.
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B A C K G R O U N D
Description of the condition
Infection with the human immunodeficiency virus (HIV) causes
a chronic, life-threatening disease, characterized by progressive
destruction of the immune system and increasing susceptibility
to infection and malignancy. Consequently, despite the availabil-
ity of highly active antiretroviral therapy (HAART), which has
revolutionized treatment, a new diagnosis of HIV carries multi-
ple threats to a person’s psychological well-being (Lawless 1996;
Hudson 2001; Colbert 2010). Being labelled with a chronic ill-
ness, especially one associated with the stigma of HIV, and the
accompanying need to take multiple daily medications with un-
pleasant side effects can lead to uncertainty about the future, rela-
tionship difficulties, social isolation, and loss of self esteem. Failure
to adjust can in turn lead to clinical depression, anxiety, stress, and
poor coping (Vanable 2006). Particularly, the prevalence of de-
pression and suicide in people living with HIV/AIDS is very high
(Cooperman 2005; Rezaee 2013; Bhatia 2014; Anagnostopoulos
2015).
Description of the intervention
Psychosocial group interventions, by definition, include some
form of psychological therapy such as cognitive behavioural ther-
apy (CBT) delivered in a group format. However, many will also
include additional components that may also have effects on psy-
chological well-being, such as: relaxation techniques and stress
management; problem solving and coping skills; social or peer
support; and education and empowerment (see Figure 1).
Figure 1. Conceptual framework
How the intervention might work
Psychological well-being is usually conceptualized as some combi-
nation of positive affective states such as happiness and function-
ing, with optimal effectiveness in individual and social life (Deci
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2008). As summarized by Huppert 2009 (p.137): “Psychological
well-being is about lives going well. It is the combination of feeling
good and functioning effectively”. By definition therefore, people
with high psychological well-being report feeling happy, capable,
well-supported, and satisfied with life.
Fundamentals to psychological well-being for HIV-positive peo-
ple are positive coping strategies and perceived social support
(Friedland 1996; Côté 2002; Turner-Cobb 2002). As compared
to individual therapy, group therapy is believed to confer a wider
range of psychosocial benefits. In a well-functioning group, mem-
bers may give and receive motivational support and encourage-
ment for self-efficacy, and through shared experiences can em-
power each other to access services, adhere to treatment, and cope
with stigma and stress (Kelly 1998; Metcalfe 1998; Moneyham
1998; Gielen 2001; Walker 2002; Peterson 2003). This is con-
trasted with the problem of stigma inherent in joining groups de-
fined by HIV-status (Roopnaraine 2012). Being in a group helps
participants to feel they are not alone in dealing with their prob-
lems and also encourages relating to yourself and others in health-
ier ways. Group formats are also cost effective and resource effec-
tive, reaching more patients than individual or one-on-one thera-
pies. This is advantageous, particularly in resource-poor settings.
Why it is important to do this review
A positive diagnosis of HIV means a lifetime of medical treat-
ment, but also dealing with the psychological effects of living with
a chronic disease. Psychosocial interventions focus on stress man-
agement, coping, and self efficacy and have the potential to have a
positive effect on peoples’ mental health and treatment adherence.
However, the evidence base of what works to improve the psy-
chological well-being of people living with HIV, particularly those
in high-risk groups and those living in resource-poor settings, is
lacking. In order to inform practice and research, this Cochrane
Review can contribute to evidence on what types of psychosocial
interventions are most effective to improve psychological well-be-
ing for HIV-positive adults. Certainty of the evidence is also im-
portant to define future studies, and whether findings are consis-
tent and can be generalized across populations and settings.
O B J E C T I V E S
To examine the effectiveness of psychosocial group interventions
for improving the psychological well-being of adults living with
HIV/AIDS.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomized controlled trials (RCTs) or quasi-RCTs with at least
three months follow-up post-intervention.
Types of participants
HIV-positive adults with and without current psychological ill-
ness.
Types of interventions
Any psychosocial intervention delivered in a group format that
aims to improve the psychological well-being of people living with
HIV. This might include the following types of interventions.
• Interventions conducted in hospitals, clinics, or community
settings.
• Interventions delivered face-to-face or via telephone or
video link.
• Interventions focused on providing information and
psychoeducation, cognitive restructuring, stress appraisal and
management, relaxation and mindfulness, adaptive and
productive coping, assertiveness training and social support.
• Interventions based on any theoretical approach.
The control intervention may be standard care, a waiting list for
future intervention, or a brief educational/psychosocial interven-
tion delivered in-group or individual format.
Types of outcome measures
Primary outcomes
• Improved psychological well-being of HIV-positive people
measured by decreases in depression scores using validated scales.
Secondary outcomes
• Measures of anxiety using validated scales.
• Measures of stress using validated scales.
• Measures of coping using validated scales.
All outcomes must be measures at baseline, post-intervention and
at a time point at least three months after the intervention.
Search methods for identification of studies
The HIV/AIDS Information Specialist, Joy Oliver, assisted the
review author team to identify trials for inclusion in the review.
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Electronic searches
We searched the following electronic databases up to 14 March
2016 using the search strategy presented in Appendix 1: the
CochraneCentral Register of ControlledTrials (CENTRAL) pub-
lished in the Cochrane Library (Issue 2, 2016), PubMed (MED-
LINE) (1996 to 14March 2016), and Embase (1996 to 14March
2016). We also checked Clinical Trials.gov using the search terms
in Appendix 2.
Searching other resources
We searched the reference list of all papers that matched our inclu-
sion criteria and contacted the first authors to identify any other
trial analyses that were published.
Data collection and analysis
Selection of studies
Two review authors (IVDH and NA) independently screened the
abstracts of all citations identified by the literature search to see if
any met the inclusion criteria. If an abstract was potentially rele-
vant, or it was unclear whether it was relevant or not, we accessed
the full-text paper and read it carefully to see if it the trial met the
inclusion criteria. Regarding multiple reports of the same trial, we
linked these, collated the data available in the reports, and pre-
sented these as one trial. We listed all excluded studies and their
reasons for exclusion in the ’Characteristics of excluded studies’
table. We constructed a PRISMA study flow diagram to illustrate
the study selection process.
Data extraction and management
Two review authors (IVDH and NA) independently extracted
data from the included trials using a standardized data extraction
form that included the following characteristics: citation of authors
and year, the type of trial design, population characteristics and
trial setting, eligibility criteria, type of intervention, treatment and
control group duration and components, all relevant outcomes
with measures (scales), time assessment points, percentage lost to
follow-up and results, see Appendix 3.
Assessment of risk of bias in included studies
Two review authors (IVDH and NA) independently assessed the
risk of bias of all trials included in the review using the Cochrane
’Risk of bias’ assessment tool (Higgins 2008; Higgins 2011). We
resolved any discrepancies through discussion and by consulting
the third review author, and if necessary we contacted the trial
authors for clarification.
We followed the guidance to assess whether the included trials took
adequate steps to reduce the risk of bias across the following six
domains: sequence generation; allocation concealment; blinding
(of participants, personnel, and outcome assessors); incomplete
outcome data; selective outcome reporting; and other sources of
bias.
For sequence generation and allocation concealment, we reported
the methods that the included trials used. For blinding, we de-
scribedwhowas blinded and the blindingmethod. For incomplete
outcome data, we reported the percentage of participants lost to
follow-up. For selective outcome reporting, we stated any discrep-
ancies between the methods used and the results in terms of the
outcomes measured or the outcomes reported. For other biases,
we described any other trial features that could have affected the
trial result (for example, if the trial was stopped early, or how the
use of a wait-list group may bias results because waiting-list
controls might be biased because of resentment at not receiving
an intervention, changes in disease state over time, and an absence
of engagement in care. However, blinding and randomization will
balance out this bias risk.
We categorized our risk of bias judgements as either ’low’, ’high’, or
’unclear’. Where risk of bias was unclear, we attempted to contact
the trial authors for clarification and resolved any differences of
opinion through discussion.
Measures of treatment effect
We reported results using mean difference (MD) with 95% confi-
dence intervals (95% CI), and used standardized mean difference
(SMD) values when we pooled trials using different scales.
Unit of analysis issues
The unit of analysis in all trials was the individual (HIV-positive
adult). For complicated designs, such as cluster-RCTs, we planned
to use the cluster as the unit of analysis, and planned to account
for clustering by adjusting the analysis to the same level as the
individual following the guidelines in the Cochrane Handbook for
Systematic Reviews of Interventions (Higgins 2008; Higgins 2011).
When trials had more than two treatment arms we took care to
avoid double counting of participants in the control group.
Dealing with missing data
Our primary analysis was a complete-case analysis, which included
only the participants with data at each time point.
We considered the potential for bias due to missing data in our
GRADEevaluationof the certainty of the evidence, by considering
the size of losses to follow-up, and any differential losses between
groups.
We contacted trial authors for clarification regarding missing data.
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Assessment of heterogeneity
Wedescribed clinical heterogeneity between trials by summarizing
key characteristics of the trial design, intervention, population,
and outcome measures in tables.
We assessed statistical heterogeneity by looking at forest plots to
examine the presence of overlapping CIs and using the Chi² test
using a P value of 0.10 to determine statistical significance. We
quantified heterogeneity using the I² statistic, which describes the
percentage of variability in the effect estimates and we applied the
standard categorization of heterogeneity to interpret the statistic
i.e. low heterogeneity = I² statistic value of 0% to 25%; moderate
heterogeneity = I² statistic value of 26% to 50% and high hetero-
geneity = I² statistic value of greater than 50%.
Assessment of reporting biases
We planned to use funnel plots to look for evidence of publication
bias. However, there were few included trials to facilitate this.
Data synthesis
We summarized and analysed the included trials in Review Man-
ager 5 (RevMan 5) (Review Manager 2014).
We analysed trials with different underlying psychological theo-
ries separately, and stratified the primary analysis by time point:
baseline, end of the group session, and longest follow-up.
When pooling studies was considered appropriate we used a ran-
dom-effects approach due to the clinical heterogeneity between
trials.
We created a ’Summary of findings’ for each comparison including
the four main outcomes: depression, anxiety, stress, and coping.
For each effect estimate we evaluated our confidence in the effect
by considering each of the five GRADE criteria: risk of bias, con-
sistency of effect, imprecision, indirectness, and publication bias.
When we found sufficient problems to downgrade the overall cer-
tainty of the evidence we justified these decisions using footnotes.
Subgroup analysis and investigation of heterogeneity
We explored possible causes of statistical heterogeneity by con-
ducting sub group analyses by: primary focus of the intervention,
outcome scale used, the control intervention, and gender.We only
performed these subgroup analyses when there were sufficient tri-
als to make it meaningful.
Sensitivity analysis
We did not plan to perform any sensitivity analysis.
R E S U L T S
Description of studies
Results of the search
We searched the available literature up to 14 March 2016 and
identified 2414 citations from the electronic database searches.
After discarding 1376 duplicates, we screened 1038 articles by title
and abstract. We selected abstracts that potentially matched our
inclusion criteria, and also articles where it was unclear whether or
not they fulfilled the inclusion criteria, for full-text assessment.We
excluded 942 articles and identified 96 full-text articles for further
assessment. After full-text assessment of these articles. we excluded
77 articles. These corresponded to 70 studies after we collated
them, which we listed in the ’Characteristics of excluded studies’
table. Nineteen articles met the inclusion criteria. We collated
multiple reports on the same trial, which gave 16 included trials.
We have illustrated the study selection process in Figure 2.
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Figure 2. Study flow diagram
Included studies
Sixteen randomized controlled trials (RCTs) that included 2520
HIV-positive adultsmet the inclusion criteria of this Cochrane Re-
view. Four trials exclusively recruited homosexual men (Chesney
2003; Carrico 2005; Antoni 2006; Gayner 2012), and two trials
recruited women only (Antoni 2008; Jones 2010). The remaining
trials recruited both men and women, with four specifying they
were all on antiretroviral therapy (ART) (Berger 2008; Duncan
2012; Peltzer 2012; Safren 2012), one trial recruited only those
with a history of childhood sexual abuse (Sikkema 2013), one
recruited injection drug users (Safren 2012), one recruited those
over 50 years old (Heckman 2011), and one recruited participants
with major depression (Nakimuli-Mpungu 2015). All trials ex-
cluded pregnant women (see Table 1).
Twelve trials were conducted in the USA (Chesney 2003;McCain
2003; Carrico 2005; Antoni 2006; Bormann 2006; Heckman
2007; Antoni 2008; Jones 2010; Heckman 2011; Duncan 2012;
Safren 2012; Sikkema 2013), Canada (Gayner 2012), and one in
Switzerland (Berger 2008), one in Uganda (Nakimuli-Mpungu
2015) and one in South Africa (Peltzer 2012). Recruitment was
from hospitals, clinics, drop-in centres, or community settings.
Therapy was conducted with groups of four to 15 people every
week for up to 12 weeks. All were face-to-face interventions except
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in Heckman 2007 and Heckman 2011 in which they were deliv-
ered by telephone. All interventions were delivered by postgradu-
ate trained health, psychology, or social care professionals, except
one which used lay health workers (Peltzer 2012). Sessions lasted
90 to 135 minutes, and the period of follow-up varied from three
to 15 months. The control groups ranged from wait-list, standard
care or treatment as usual, information or education only, or a
brief form of the intervention (30 minutes or one day).
We subgrouped the interventions by their underlying psycholog-
ical theory, although all the interventions were multifaceted.
• Cognitive behavioural therapy (CBT) (13 trials): a
psychotherapeutic approach that addresses dysfunctional
emotions, maladaptive behaviours, and cognitive processes
through a number of goal-oriented, problem-focused, action-
orientated procedures. The name refers to therapy based upon a
combination of basic behavioral and cognitive principles and
research. Most therapists working with patients dealing with
anxiety and depression use a blend of cognitive and behavioral
therapy. Six trials focused particularly on stress management
(McCain 2003; Carrico 2005; Antoni 2006; Antoni 2008;
Berger 2008; Sikkema 2013), three on coping (Chesney 2003;
Heckman 2007; Heckman 2011), one on self-efficacy (Jones
2010), one on adherence and depression (Safren 2012), one on
depression (Nakimuli-Mpungu 2015), and one on adherence
(Peltzer 2012).
• Mindfulness Based Stress Reduction (three trials): a
structured group programme that employs mindfulness
meditation to enhance awareness of irrational thoughts and
negative affect (Duncan 2012; Gayner 2012), and includes a
spirituality approach that involves repeating a mantram-sacred
word or phrase (Bormann 2006).
The trials reported a variety of scales for depression, anxiety, stress,
and coping (Table 2; Table 3; Table 4). We pooled these data
using standardizedmean differences, before presenting a subgroup
analysis using the same assessment scale.
Excluded studies
We excluded a total of 70 trials (77 articles) after full-text assess-
ment and listed the reasons for exclusion in the ’Characteristics of
excluded studies’ table. Some studies were not RCTs or did not
report on RCT data, and most studies did not include group inter-
ventions; this was not apparent when we only assessed the abstract.
Other trials did not have at least a three-month post-intervention
follow-up assessment. Safren 2009 invited the control to cross-
over to the intervention after three months but had no post-inter-
vention three-month follow-up. For example, we excluded Wyatt
2004 as we did not receive any response from the study author
about what data they included in the post-intervention period,
that is whether the data presented in this trial was the three-month
or six-month follow-up data; it remains unclear. Latkin 2003 and
Yu 2014 did not have HIV-positive populations. Six trials did not
measure our specified outcomes. One trial, Laperriere 2005, pre-
sented a subgroup analysis from a larger trial. Prado 2012 had a
sample of adolescents and not adults. Sacks 2011 did not report
on effects for the group intervention.
We excluded seven trials conducted in Africa: Papas 2011 inWest-
ern Kenya measured reductions in alcohol use in people on an-
tiretroviral (ARV) treatment using a CBT intervention so did not
include a specified outcomes, Olley 2006 in Nigeria measured
psychological distress, risky sexual behaviour, and self-disclosure
of HIV using an individual psychoeducation intervention rather
than a group intervention, Mundell 2011measured rates of disclo-
sure and active and avoidant coping in pregnant and recently diag-
nosed HIV-positive women in South Africa participating in struc-
tured up support groups, but this was not an RCT. Petersen 2014’s
trial on a group-based counselling intervention for depression in
South Africa did not have a three-month follow-up postinterven-
tion. Petersen 2014 also had a very small sample size. Kunutsor
2011’s trial was based in Uganda but was a treatment supporter
intervention and not a group intervention, and Jones 2005’s trial
among HIV positive women in Zambia did not have a control
group. Kaaya 2013’s trial in Tanzania measured prenatal HIV dis-
closure and depression, however we excluded it because there was
no three-month post-intervention follow-up.
Risk of bias in included studies
For a summary of the ’Risk of bias’ assessments see Figure 3 and
Figure 4.
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Figure 3. ’Risk of bias’ summary: review authors’ judgements about each ’Risk of bias’ item for each
included trial
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Figure 4. ’Risk of bias’ graph: review authors’ judgements about each ’Risk of bias’ item presented as
percentages across all included trials
Allocation
We only included ’randomized’ trials. However, only Berger 2008
provided enough detail of the methods to be considered at low
risk of selection bias. All other included trials were at unclear risk
of selection bias.
Blinding
True blinding of participants to the types of interventions evalu-
ated in this review is rarely possible. Trial authors did not describe
blinding sufficiently. However, it is possible to blind those con-
ducting the analysis but only one trial described the methods to
achieve this and we judged it to be at low risk of detection bias
(Safren 2012). All other trials were at unclear risk of detection bias.
Incomplete outcome data
Fourteen trials reported high levels of loss to follow-up in at least
one treatment arm over the duration of the trial (greater than
20%), or differential losses between groups, which had the poten-
tial to bias the results. Consequently we only judged two included
trials to be at low risk of attrition bias (Duncan 2012; Peltzer
2012).
Selective reporting
We found no evidence of selective reporting and we considered all
included trials as at low risk of reporting bias.
Other potential sources of bias
Bormann 2006 and Safren 2012 noted some imbalances in po-
tential confounders between the intervention and control groups
at baseline. We judged these trials to be at unclear risk of bias. All
other included trials were at low risk of other sources of bias.
Effects of interventions
See: Summary of findings for the main comparison ’Summary
of findings’ table 1; Summary of findings 2 ’Summary of findings’
table 2
See ’Summary of findings’ table 1 (Summary of findings for the
main comparison) and ’Summary of findings’ table 2 (Summary of
findings 2). We have presented the findings by intervention type.
Comparison 1: Group therapy (CBT) versus control
See ’Summary of findings’ table 1 (Summary of findings for the
main comparison).
Thirteen trials evaluated group therapy sessions based on cogni-
tive behavioural therapy (CBT) techniques. Ten trials were deliv-
ered face-to-face (Chesney 2003; McCain 2003; Carrico 2005;
Antoni 2006; Antoni 2008; Berger 2008; Jones 2010; Peltzer
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2012; Nakimuli-Mpungu 2015) and two were delivered by tele-
phone (Heckman 2007; Heckman 2011). The primary focus of
CBT was stress reduction or coping (nine trials), self-efficacy (one
trial), depression (one trial), adherence (one trial), and adherence
and depression (one trial). Eight trials described additional relax-
ation components such as progressive muscle relaxation (PMR)
or meditation, four explicitly described methods to facilitate peer/
group support, and six described specific educational components.
Most sessions lasted between 50 and 135 minutes, were conducted
weekly for between eight and 12 weeks, and included between
four and 12 participants (Table 5).
Fourteen trialswere fromhigh-income settings (USA,Canada, and
Switzerland). Two trials were from low- ormiddle-income settings:
South Africa (Peltzer 2012), and Uganda (Nakimuli-Mpungu
2015). Five trials were conducted among general populations,
three trials with homosexual men, one trial with women from
minority groups, one trial with women with an abnormal cervi-
cal smear, one trial among prior intravenous drug users, one trial
among people with a history of being abused, and one trial among
people with adherence problems (see Table 1).
Depression scores
Overall, there was a small reduction in mean depression scores
at the end of the group sessions (standardized mean difference
(SMD) −0.17, 95% confidence interval (CI) −0.29 to −0.05;
1142 participants, 9 trials; low certainty evidence; Analysis 1.1),
and this appeared to be maintained for up to 15 months after
randomization (SMD −0.26, 95% CI −0.42 to −0.10; 1139
participants, 10 trials, low certainty evidence; Analysis 1.1).
The most commonly used depression score was Beck Depression
Inventory (BDI) (used by six trials), which scores depression out
of 63. The overall effect was a reduction of around 1.4 points
(mean difference (MD) −1.41, 95% CI −2.61 to −0.21; 753
participants, 6 trials, Analysis 1.2). See Table 2 for a description
of the different depression scores that the included trials used.
Mean depression scores at baseline were in the depressive range
in five trials. Over the duration of these trials, there was a modest
improvement in mean score in both the intervention and control
groups, but only two trials showed increased benefit with the in-
tervention (Analysis 1.3). In the remaining five trials mean depres-
sion scores were in the normal range at baseline, and there was a
small but consistent reduction inmean score with the intervention
(Analysis 1.5).
We conducted additional subgroupingby the type of control group
used (Analysis 1.4), the primary focus of the intervention (Analy-
sis 1.6), and gender (Analysis 1.7). The most consistent effects on
depression were from three trials that focused on stress manage-
ment interventions (SMD−0.46, 95% CI −0.73 to−0.18; 216
participants, 3 trials).
Anxiety scores
Four trials assessed measures of anxiety, and overall there was no
effect apparent at the end of the group sessions (SMD−0.01, 95%
CI−0.25 to 0.22; 420 participants, 3 trials, low certainty evidence),
or at 12 to 15 months after randomization (SMD −0.12, 95%
CI−0.31 to 0.06; 471 participants, 4 trials, low certainty evidence;
Analysis 1.8).
All four trials used different anxiety scales, and only one trial (us-
ing the Hospital Anxiety and Depression Scale) reported a statis-
tically significant effect (see Table 3 and Analysis 1.9). This study
was conducted in Switzerland among the general population, and
baseline and end anxiety scores were in the normal range (Berger
2008). Only the participants recruited by Chesney 2003 appeared
to have substantial anxiety at baseline, and although there was a
small improvement in both groups over the course of the trial,
there were no differences between groups at any time point.
Stress scores
Five trials assessed measures of stress, and overall there was no
effect apparent at the end of group sessions (SMD−0.06, 95%CI
−0.23 to 0.12; four trials, 533 participants, low certainty evidence,
Analysis 1.11), or at the end of follow-up (SMD −0.04, 95% CI
−0.23 to 0.15; five trials, 507 participants, low certainty evidence,
Analysis 1.11). Only Antoni 2008, which was conducted among
HIV-positive womenwith a recent abnormal cervical smear, found
a statistically significant effect at any time point. For a description
of the stress scores used see Table 4 and Analysis 1.12.
Coping scores
Five trials reported some measure of coping with no effects seen
at the end of group therapy (SMD 0.02, 95% CI −0.16 to 0.19;
762 participants, 5 trials; low certainty evidence, Analysis 1.14), or
at the end of follow-up (SMD 0.04, 95% CI −0.11 to 0.19; 697
participants, 5 trials; low certainty evidence; Analysis 1.14). In all
measures of coping, higher scores reflected increased coping (see
Table 6 and Analysis 1.15).
Comparison 2: Group therapy (mindfulness) versus
control
Three trials evaluated face-to-face group therapy sessions based
on mindfulness stress reduction (Bormann 2006; Duncan 2012;
Gayner 2012). The interventions included mindfulness medita-
tion, with one intervention including mantram repetition and
one described additional educational components. Group sessions
lasted between 135 and 180 minutes, and were conducted weekly
for eight to 10 weeks, plus one day retreat, The group size was
eight to 18 participants across trials (see Table 7).
All trials were conducted in high-income settings. One trial was
conducted amonghomosexualmen inCanada (Gayner 2012), one
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trial was among men and women experiencing some side effects
or distress in the USA (Duncan 2012), and the other included
trial was among men and women (50%) who were homosexual
(Bormann 2006) (see Table 1).
Depression scores
Individually, none of these trials reported statistically significant
effects on mean depression scores. The pooled effect suggests a
modest reduction in mean scores at the end of the group sessions
(SMD −0.22, 95% CI −0.48 to 0.04; 242 participants, 3 tri-
als; very low certainty evidence, Analysis 2.1), and at six months
postrandomization (SMD −0.23, 95% CI −0.49 to 0.03; 233
participants, 3 trials;very low certainty evidence; Analysis 2.1), but
the 95% CIs were wide and included no effect.
Anxiety scores
Bormann 2006 and Gayner 2012 measured anxiety scores using
different measurement scales. There were no statistically signifi-
cant differences in the mean scores at the end of the group sessions
(SMD −0.23, 95% CI −0.53 to 0.07; 178 participants, 2 trials,
very low certainty evidence; Analysis 2.2), or at six months (SMD
−0.16, 95% CI−0.47 to 0.15; 162 participants, 2 trials, very low
certainty evidence; Analysis 2.2).
Stress scores
Bormann 2006 andDuncan 2012 measured stress scores using the
perceived stress score, A small statistically significant difference was
present at the end of group sessions (MD −2.29, 95% CI −4.46
to −0.11; 139 participants, 2 trials; very low certainty evidence),
but not at six months postrandomization (MD −2.02, 95% CI
−4.23 to 0.19; 137participants, 2 trials, very low certainty evidence;
Analysis 2.3). The effect size was around 2 points on a 40-point
scale.
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Group therapy (mindfulness) compared to control for improving psychological well-being in adults living with HIV
Patient or population: adults living with HIV
Settings: any sett ing
Intervention: group therapy based on mindfulness
Outcomes Illustrative comparative risks* (95% CI) Number of participants
(trials)
Certainty of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Control Group therapy (M indful-
ness)
Depression score
Follow-up: 4 to 6 months
The mean scores in the con-
trol groups at the end of fol-
low-up were in the range of
normal to mild depression
The mean score in the inter-
vent ion groups was
0.23 standard deviations
(SDs) lower
(0.49 lower to 0.03 higher)
233
(3 trials)
⊕©©©
very low1,2,3,4
due to risk of bias, indirect-
ness, and imprecision
We don’t know if there
is a benef it on depression
scores
Anxiety score
Follow-up: 4 to 6 months
The mean scores in the con-
trol group at the end of fol-
low-up were in the range of
normal to mild anxiety
The mean score in the inter-
vent ion groups was
0.16 SDs lower
(0.47 lower to 0.15 higher)
162
(2 trials)
⊕©©©
very low1,3,4
due to risk of bias, indirect-
ness, and imprecision
We don’t know if there is
an ef fect on mean anxiety
scores
Stress score
Follow-up: 4 to 6 months
The mean scores in the con-
trol group at the end of fol-
low-up were in the range of
mild stress
The mean score in the inter-
vent ion groups was
2.02 points lower
(4.23 lower to 0.19 higher)
137
(2 trials)
⊕©©©
very low1,3,4
due to risk of bias, indirect-
ness, and imprecision
We don’t know if there is
an ef fect on mean stress
scores
Coping score
Follow-up: no coping was
measured by mindfulness
intervent ion trials
- - 0
(0 trials)
- -
1
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Studies used a variety of dif f erent scales to measure depression, anxiety and stress. Consequent ly, trials were pooled using a standardized mean dif ference. Examples of how
large this ef fect would be on standardized measurement scales are given in the review main text and abstract.
Abbreviations: CI: conf idence interval; OR: odds rat io; SD: standard deviat ion
GRADE Working Group grades of evidence
High certainty: f urther research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate certainty: f urther research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low certainty: f urther research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low certainty: we are very uncertain about the est imate.
1Downgraded by 1 for serious risk of bias: none of the trials adequately described a method of allocat ion concealment, and
so trials are at unclear or high risk of select ion bias. Loss of follow-up was generally more than 20% and attrit ion bias may
be present.
2No serious inconsistency: stat ist ical heterogeneity between trials was low.
3Downgraded by 1 for serious indirectness: these three trials were conducted in the USA and Canada in people with scores in
the range of mild to moderate depression. The results are not easily generalized to other sett ings or populat ions.
4Downgraded by 1 for serious imprecision: the 95% CI are wide and includes both potent ially important ef fects and no ef fect.
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D I S C U S S I O N
Summary of main results
Group-based psychosocial interventions based on cognitive be-
havioural therapy (CBT) may have a small effect on measures of
depression, and this effect may last for up to 15 months after par-
ticipation in the group sessions (low certainty evidence). Most trials
used the BeckDepression Inventory (BDI) which has a maximum
score of 63, and the mean score in the intervention groups was
around 1.4 points lower at the end of follow-up. This small benefit
was consistent across five trials where participants had a mean de-
pression score in the normal range at baseline, but trials where the
mean score was in the depression range at baseline effects were less
consistent. Fewer trials reported measures of anxiety (low certainty
evidence), stress (low certainty evidence), and coping (low certainty
evidence), and there was no clear evidence of effects.
Group-based interventions based onmindfulness have not demon-
strated effects on measures of depression (very low certainty evi-
dence), anxiety (very low certainty evidence), or stress (very low cer-
tainty evidence).
Overall completeness and applicability of
evidence
Most of the trial interventionswere based on cognitive-behavioural
approaches, which were delivered in similar ways (with similar
group sizes, similar trained facilitators, and similar numbers of ses-
sions). Most included trials were conducted in high-income set-
tings (USA, Canada, and Switzerland). Two trials of CBT were
conducted in low- and middle-income countries, which is where
the prevalence of HIV is highest; over 95% of HIV infections are
in low- and middle-income countries, two-thirds of them in sub-
Saharan Africa (Boyle 2016). One trial was conducted among an
urban population inUganda andmeasures of depression improved
significantly in both the intervention and control groups over the
course of the study (greater than 10 points on a 20-point scale)
with only small differences between groups (2.5 points). The small
effects in the Uganda trial are unlikely to be cost-effective where
resources and trained staff are scarce. The trial conducted among
depressed adults on ART in South Africa showed no effects be-
tween the two groups for depression.
One of the main aims of this Cochrane Review was to evaluate
whether effects seen at the end of group sessions persisted, or were
lost, and our findings do seem to suggest that improvements at the
end of group session are sustained for up to 15 months. However,
as over half the included trials had mean scores at baseline within
the normal range (not depressed), the clinical significance of this
effect is unclear. In trials that did contain people with measurable
depression the effects were inconsistent and there were too few
trials to explore why some interventions seemed to have a benefit
and some did not.
The included trials used a variety of measurement scales to assess
each outcome which made pooling of studies and comparison
across population groups difficult.
Quality of the evidence
Werated the certainty of the evidence for a small effect onmeasures
of depression with CBT group therapy as ’low’ meaning we can
only have low confidence in the observed effect. We downgraded
the evidence from high to low due to ’risk of bias’: as most studies
were at unclear risk of selection bias and high risk of attrition bias,
and due to ’indirectness’ of the evidence (with most trials being
from high income settings), and the difficulty in generalising the
findings to other settings and population groups. We also rated
the evidence of no effect on anxiety, stress, and coping as ’low’ for
the same reasons.
For mindfulness-based group interventions, we rated all outcomes
as ’very low’ meaning we are very uncertain about the observed
effect. We downgraded the evidence for ’risk of bias’ due to defi-
ciencies in the study methods, ’indirectness’ due to the difficulty
generalising the findings to other populations and settings, and
’imprecision’ as the effect is towards benefit but the 95% CI are
wide and include no effect.
Potential biases in the review process
The inclusion criteria of this Cochrane Review may increase the
possibility of poor reproducibility due to many subjective deci-
sions regarding which studies and populations to include. We in-
cluded all HIV-positive populations (both genders) and we had no
exclusion criteria regarding settings when we selected studies for
inclusion. However, weminimized this potential bias by including
stringent follow-up time criteria and only RCTS.
We only assessed peer-reviewed published trials, which may have
led to exclusion of trials in grey literature and presented at con-
ferences. Having no knowledge of unpublished studies may have
limited the assessment of the strength of the body of evidence in
the review. Another limitation is that we only included papers that
reported in English, thus disregarding high quality trials that may
have been published in other languages.
We selected only trials that used validated scales, which is a strength
of the review. We amended specified outcomes by only including
psychological outcomes and no longer behavioural outcomes after
we realized that there were poor or invalidated assessments for be-
havioural outcomes in the first set of literature search results (June
2013). Our decision to change specified outcomes after seeing the
results for included studies could have lead to biased and mislead-
ing interpretation if the importance of the outcome (primary or
secondary) is changed on the basis of those results. We have pro-
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vided transparency in the reporting of changes in outcome speci-
fication to reduce this risk of bias.
Even when review authors have a common understanding of the
selection criteria, random error or mistakes may result from in-
dividual errors in reading and reviewing studies. We reduced this
potential bias by ensuring that all review authors read the papers
and extracted data independently, and then came to mutual agree-
ments.
We noted issues regarding poor reporting in the papers and we
were unable to obtain all relevant data due to the lack of responses
from study authors about missing data or clarification of data.
Agreements and disagreements with other
studies or reviews
To our knowledge, no published systematic review has assessed
the psychological impact of psychosocial group interventions for
HIV positive adults.
The findings of this Cochrane Review are in contrast to a nar-
rative review (Brown 2011), as well as older meta-analysis syn-
theses (Crepaz 2008; Scott-Sheldon 2008), of the effect of vari-
ous group interventions on outcomes for improvedmental health.
These report on how stressmanagement and cognitive behavioural
interventions and mindfulness-based interventions are effective
in improving various psychological states in people living with
HIV. However, Crepaz 2008 did not assess the randomization
method, allocation concealment, and blinding used by the trials,
thus making data extraction and quality assessment less rigorous.
Scott-Sheldon 2008’s meta-analytic review of RCTs of stress-man-
agement interventions showed significant overall impact on men-
tal health, whereas Brown 2011’s narrative critique of the effec-
tiveness of mindfulness based intervention is the only review of the
effectiveness of mindfulness-based interventions on mental health
that we found. However, the Brown 2011 review is undermined
by inclusion of trials that did not fit our stringent inclusion cri-
teria that trials must have had longer than three months follow-
up in order to show sustained effects, and did not include a meta-
analysis. Similar to our Cochrane Review, current published re-
views on this subject mainly include trials in high-income settings,
which makes a strong case for high quality research to be funded
and motivated for marginalized populations where HIV is most
prevalent.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Group-based psychosocial interventions may have a small but sus-
tained effect on measures of depression. However, the clinical im-
portance of this is unclear as we only consistently observed the
small effect in trials where the mean score of participants in both
the intervention and control groups was in the normal range (not
depressed) for the duration of the trial.
Implications for research
Further trials that include people with signs of depression, stress,
or poor coping at baseline will provide evidence of improving
psychological adjustment and coping for those who need it most.
Further randomized studies should also meet current standards in
reporting of methods as outlined in the CONSORT statement
and take appropriate steps to reduce the risk of bias.
To enable a clear understanding of the results, and facilitate future
meta-analyses, it would also be useful if this research field utilized
a common set of outcome scales rather than the ad-hoc selection
that is seen across the included studies.
Additionally, evidence is lackingwhereHIV prevalence is the high-
est. This indicates a need for strengthening trial research capacity
in low- and middle-income settings.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Antoni 2006
Methods Trial design: 2-arm randomized controlled trial (RCT)
Follow-up: 3, 9, and 15 months follow up
Loss to follow-up: 22 in treatment group, 23 in control group
Participants Population: 130 HIV-positive homosexual men receiving highly active antiretroviral
therapy (HAART); intervention = 76, control = 54
Inclusion criteria: 18 to 65 years old, no changes in their HAART regime during past
month
Exclusion criteria: prescribed medications with immunomodulatory effects, history of
chemotherapy or whole-body radiation for cancer that was not AIDS-related, history of
chronic illness associated with permanent changes in immune system
Interventions Intervention: N = 76. Cognitive Behavioural Stress Management (CBSM): focused on
eliciting participant experiences with adherence and medication side effects using cog-
nitive restructuring exercises, managing stressors related to adherence, using productive
coping responses
• Group size: 2 to 9.
• Facilitators: postdoctoral fellows and advanced clinical health psychology graduate
students.
• Session duration: 135 mins (45 mins relaxation component and 90 mins stress
management component).
• Session frequency: 10 weekly sessions.
• Additional components: relaxation including progressive muscle relaxation
(PMR), autogenic training, meditation and deep breathing: participants were asked to
practice these between sessions. + Medication adherence training
Control:N = 54. Medication adherence training (MAT): aimed to increase knowledge
about HIV and HAART, including how medications work, why they must be taken on
time and at the proper dose, and how to recognize possible side effects
• All participants received MAT from a licensed clinical pharmacist in a 1-hr session
at baseline as well as two 30-min maintenance sessions at 3 months and 9 months
postrandomization, respectively.
Outcomes Included in this review
• Depression by Becks Depression Inventory (BDI) and Profile Of Moods Scale -
Depression (POMS-D).
• Anxiety by Profile Of Moods Scale - Anxiety (POMS-A).
Not included in this review
• Immunological outcomes: viral load and CD4.
• Adherence by Medication Event Monitoring System (MEMS).
Notes Used 2 scales to measure depression POMS-D and BDI; we chose BDI
Setting: not reported
Country: USA
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Antoni 2006 (Continued)
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Participants identification num-
bers were drawn randomly from a box for
assignment to trial conditions.”
Allocation concealment (selection bias) Unclear risk Quote: “Randomization procedures were
conducted by a master’s level project man-
ager and overseen by the principal investi-
gator. Participants identification numbers
were drawn randomly from a box for as-
signment to trial conditions.” No further
details
Blinding of participants and personnel
(performance bias)
Anxiety
Unclear risk The trial authors did not describe the
method of blinding, if any
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk The trial authors did not describe the
method of blinding, if any
Incomplete outcome data (attrition bias)
All outcomes
High risk Loss to follow-up: 19.7% intervention
group versus 25.9% control. Intention-to-
treat (ITT) analysis done
Selective reporting (reporting bias) Low risk We did not detect any selective reporting
bias.
Other bias Low risk We did not detect any other sources of bias.
Antoni 2008
Methods Trial design: 2-arm RCT
Follow-up: 9-month follow-up
Loss to follow-up:Cognitive Behavioral Stess Management (CBSM) group: 47% com-
pleted follow-up; control participants: 69% completed follow-up
Participants Population: 39 HIV-positive African American, Hispanic, or Caribbean women. Inter-
vention = 21, control = 18
Inclusion criteria:HIV-positive women aged 18 to 60 years old; at least 2 Papanicolaou
smears indicating low grade squamous intraepithelial lesions (LSIL) or al least 2 cervical
biopsies indication CIN 1 (mild or grade 1 neoplasia) in the 2 years prior to trial entry;
fluency in spoken English
Exclusion criteria: no exclusion criteria were listed.
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Antoni 2008 (Continued)
Interventions Treatment: N = 21. Cognitive behavioural training (CBT) that increased awareness of
the effects of stress, identifying and reframing automatic thoughts, improving productive
coping skills, anger management, assertiveness training, productive use of one’s social
network, and safer sex negotiation
• Group size: 4 to 6.
• Facilitators: doctoral trainees, postdoctoral fellows, and licensed psychologists.
• Session duration:135 mins (45 mins relaxation training and 90 mins of cognitive
behavioural training).
• Session frequency: 10 weekly sessions.
• Additional components: weekly homework was assigned, including stress
monitoring and relaxation practice.
Control:N = 18. 5-hour 1-day CBSM workshop with four 20-minute relaxation mod-
ules, four 40-minute CBSM modules, and two 30-minute breaks
Outcomes Included in this review
• Life Stress measured using 10-item abbreviated form of Life Experiences Survey
(LES; Sarason, Johnson & Siegel 1978)
Not included in this review
• CD4 and plasma HIV viral load.
• Cervical intraepithelial neoplasia (CIN).
Notes Jensen 2013 did secondary analysis on psychological well-being but only used a subset
of Beck Depression Inventory (BDI)
Setting: not reported
Country: USA
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “randomly assigned to either the
10-week CBSM group intervention or the
one-dayCBSMworkshop at a 2:1 ratio (ex-
perimental:control)”. No further details
Allocation concealment (selection bias) Unclear risk Quote: “Participants and assessors were
blinded to experimental condition during
completion of all study entry procedures”.
No further details
Blinding of participants and personnel
(performance bias)
Anxiety
Unclear risk The trial authors did not describe the
method of blinding, if any
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk The trial authors did not describe the
method of blinding, if any
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Antoni 2008 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
High risk Loss to follow-up: 43.2% intervention
group versus 21.7% control. Trial authors
conducted an ITT analysis
Selective reporting (reporting bias) Low risk We did not detect any selective reporting
bias.
Other bias Low risk We did not detect any other sources of bias.
Berger 2008
Methods Trial design: 2-arm RCT
Follow-up: 12 months
Loss to follow-up: intervention loss n = 2; treatment loss n = 4
Participants Population: 104 HIV-positive people taking combination antiretroviral therapy (ART)
, intervention = 53, control = 51
Inclusion criteria: adults between 18 to 65 years, German speaking, received combina-
tion Antiretroviral Therapy (cART) within the 3 months prior to screening, had a CD4
lymphocyte count > 100 cells/µL and no opportunistic infection at baseline
Exclusion criteria: received psychotherapy in past 3 months, intravenous drug users or
on stable methadone maintenance, diagnosis of psychiatric disorder as determined by
standardized interview
Interventions Treatment: N = 53. Psychoeducation, group dynamics exercises, homework, cognitive
strategies, and PMR
• Group size: 4 to 10.
• Facilitators: cognitive behavioural psychotherapist and one psychotherapist
trainee.
• Session duration: 120 minutes.
• Session frequency: 12 weekly sessions.
Control:N = 51. 30-minute health check by physician.
Outcomes Included in review
• Anxiety and Depression by HADS.
Not included in review
• CD4 lymphocyte cell count and HIV-1 RN.
• Adherence to therapy (SMAQ).
• Physical and Mental Health (MOS-HIV).
Notes Ethics approval.
Setting: outpatient clinics
Country: Switzerland
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
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Berger 2008 (Continued)
Random sequence generation (selection
bias)
Low risk Quote: “Allocation sequences included
randomly permuted block sizes of two and
four and were generated using the com-
puter program RANCODE V3.0”
Allocation concealment (selection bias) Low risk Quote: “Individual assignment codes were
properly concealed between black sheets,
stored in sequentially numbered envelopes
and opened in the presence of study partic-
ipants”
Blinding of participants and personnel
(performance bias)
Anxiety
Unclear risk The trial authors did not describe the
method of blinding, if any
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk The trial authors did not describe the
method of blinding, if any
Incomplete outcome data (attrition bias)
All outcomes
High risk Losses to follow-up: 37.7% intervention
group versus 25.5% control group.Trial au-
thors conducted an ITT analysis
Selective reporting (reporting bias) Low risk We did not detect any selective reporting
bias.
Other bias Low risk We did not detect any other sources of bias.
Bormann 2006
Methods Trial design: RCT 2 group by 4 time repeated measures design
Follow-up: baseline, 10 weeks, 3 months follow-up, 22 weeks post follow-up
Loss to follow-up: 71% completed all trial points
Participants Population: 93 HIV-positive adults, intervention = 46, control = 47
Inclusion criteria:HIV-positive for≥ 6months; 18 to 65 years old; no drug or substance
abuse for ≥ 6 months; able to read, write, and comprehend English
Exclusion criteria: Trial authors did not list any exclusion criteria.
Interventions Treatment: N = 46. Information on choosing and using a mantram, attention to mind-
fulness, phone calls to encourage mantram practice
• Group size: 8 to 15.
• Facilitators: led by the same 2 Masters’ prepared psychiatric mental health nurses.
• Session duration:135 mins (45 mins relaxation training and 90 mins of cognitive
behavioural training).
• Session frequency: 10 weekly sessions: 5 x 90 min weekly sessions, followed by 4
weekly automated phone calls from facilitators and a final session in week 10.
Control: N = 47. Videotapes on HIV topics including medications, treatment issues,
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Bormann 2006 (Continued)
wasting syndrome, and nutrition. Attention control group the same
Outcomes Included in review
• Stress using the Perceived Stress Scale (PSS).
• Anxiety using the Spielberger Trait-Anxiety Inventory (STAI).
• Depression using the Centre for Epidemiological Studies-Depression Scale (CES-
D).
Not included in review
• Quality of Life assessed with the Overall-General Activities sub-scale from the
Quality of Life Enjoyment and Satisfaction Questionnaire.
• Anger using the Spielberger Trait-Anger Inventory (STAI).
Notes 50% homosexual participants
Setting: not reported
Country: USA
University Institutional Review Board approval
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Random assignment was done by
the project coordinator using a table of
random numbers and stratifying on CD4
count”
Allocation concealment (selection bias) Unclear risk Trial authors did not describe selectionbias.
Blinding of participants and personnel
(performance bias)
Anxiety
Unclear risk Trial authors conducted an ITT analysis.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk The trial authors did not describe the
method of blinding, if any
Incomplete outcome data (attrition bias)
All outcomes
High risk Losses to follow-up: 30.4% intervention
group versus 27.7% control group
Selective reporting (reporting bias) Low risk We did not detect any selective reporting
bias.
Other bias Unclear risk Groups differed on 4 baseline variables;
“baseline imbalance”
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Carrico 2005
Methods Trial design: 2-arm RCT
Follow-up: pre, post, 6 months, and 12 months
Loss to follow-up: 50% followed up in intervention and 47% in control.
Participants Population: 129 HIV seropositive homosexual men. Intervention = 31, control = 18
Inclusion criteria: have at least 1 non-AIDS HIV-related symptom occurring within 3
years of trial entry of laboratory signs of mildly progressed HIV infection, have at least
an 8th grade education and ability to read and write in fluent English, CD4 counts >
200 cells/mm³, those on AZT or ART had to have maintained current dosage without
change in regimen for at least 2 months before trial entry, those concurrently engaged
in psychotherapy or support groups were asked not to change their involvement during
the trial
Exclusion criteria: individuals with AIDS symptomology, a prior diagnosis of AIDS
(CD4 count < 200 cells/mm³), those who had been hospitalized in previous 3 months,
those who had a chronic immune system-related physical condition other than HIV
and regular use of medications (other than ARVs) with substantial known effects on the
endocrine or immune systems, those with psychiatric or neuropsychological conditions,
alcohol or substance abuse dependency, or andmajor psychiatric andpersonality disorder,
who were cognitively impaired, patients with concurrent clinical levels of depression,
individuals who had been bereaved of a significant other within the previous 6 months,
risk factors for HIV transmission other than sexual orientation (for example, past or
present intravenous drug use, blood transfusion), initiating a new psychotherapy or
exercise training programme in past 3 months
Interventions Treatment:N= 31. CBSM (GET SMART) included increasing awareness of physiolog-
ical effects of stress, cognitive behavioural theory of stress and emotions, identification
of cognitive distortions and automatic thoughts, rational thought replacement, coping
skills training, assertiveness training, anger management, and identification and use of
social supports. Homework was assigned and participants were taught a variety of relax-
ation techniques including PMR, autogenic training, meditation and breathing exercises
• Group size: 4 to 9 men.
• Facilitators: 2 advanced clinical-health psychology graduate students.
• Session duration: 135-minute group sessions (90-minute stress management and
45-minute relaxation) and were asked to complete relaxation exercises twice daily
between sessions.
• Session frequency: 10 weekly sessions.
Control: N = 18. Waitlist, 2 weeks post treatment they were offered a 1 day seminar
consisting of condensed CBSM components
Outcomes Included in review
• Depression by BDI.
Not included in review
• Mood by Profile of Mood States (POMS-TMD).
• Social Support by Social Provisions Scale (SPS).
• CD4 by blood sample.
• Herpes Virus by IgG antibodies.
• DHEA-S and cortisol.
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Carrico 2005 (Continued)
Notes Setting: not reported
Country: USA
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk The trial authors described the trial as “ran-
domized” but did not provide any further
details
Allocation concealment (selection bias) Unclear risk The trial authors did not describe selection
biases, if any.
Blinding of participants and personnel
(performance bias)
Anxiety
Unclear risk The trial authors did not describe the
method of blinding, if any
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk The trial authors did not describe the
method of blinding, if any
Incomplete outcome data (attrition bias)
All outcomes
High risk Losses to follow-up: 66.3% intervention
group versus 65.2% control group
Selective reporting (reporting bias) Low risk We did not detect any selective reporting
bias.
Other bias Low risk We did not detect any other sources of bias.
Chesney 2003
Methods Trial design: 3-arm RCT
Follow-up: 6 and 12 months
Loss to follow-up: 86% retained
Participants Population: 149 HIV-positive men who have sex with men (MSM) and who have
depression
Inclusion criteria: (1) self-identified as homosexual or bisexual, (2) 21 to 60 years of
age, (3) self-reported CD4 levels between 200 and 700 cells/mm³
Exclusion criteria: (1) individuals with major depressive or psychotic disorders, (2)
history of drug or alcohol dependency in past year, (3) currently in psychotherapy, (4)
using psychoactive medication
Interventions Treatment:N = 54. Coping Effectiveness Training (CET) comprising psychoeducation:
appraisal of stressful situations, problem-focused and emotion-focused coping, use of
social support; skills-building group activities, relaxation guidance
• Group size: 8 to 10.
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Chesney 2003 (Continued)
• Facilitators: co-leaders with graduate experience in social work and clinical
psychology or community-based HIV services.
• Session duration: 90 minutes.
• Session frequency: 10 weekly plus 6 maintenance sessions.
• Additional components: a day-long retreat and take home activities.
Control: N = 51. HIV-Informational Control comprising Didactic information on
HIV-related topics and resources, workbooks, fact sheets, and reading material
10 weekly 90-minute group sessions of 8 to 10 men plus 6 maintenance sessions
Waiting list: N = 44. Waiting list control
Outcomes Included in review
• Depression by CES-D.
• Stress by PSS.
• Anxiety by STAI.
Not included in review
• Burnout (own scale developed).
• Negative Morale and Positive morale (Affect Balance Scale).
Mediating variables
• Coping self-efficacy.
• Social support.
• Optimism.
• Positive state of mind.
Notes Setting: not reported
Country: San Francisco, USA
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk The trial authors described the trial as “ran-
domized” but did not provide any further
details
Allocation concealment (selection bias) Unclear risk The trial authors did not describe selection
bias, if any.
Blinding of participants and personnel
(performance bias)
Anxiety
Unclear risk The trial authors did not describe the
method of blinding, if any
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk The trial authors did not describe the
method of blinding, if any
Incomplete outcome data (attrition bias)
All outcomes
High risk Loss to follow-up: 33.3% intervention ver-
sus 33.3% control.
35Psychosocial group interventions to improve psychological well-being in adults living with HIV (Review)
Copyright © 2017 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
Chesney 2003 (Continued)
Selective reporting (reporting bias) Low risk We did not detect any selective reporting
bias.
Other bias Low risk We did not detect any other sources of bias.
Duncan 2012
Methods Trial design: 2-arm RCT
Follow-up: baseline, 3 month and 6 month follow-up
Loss to follow-up: 93% 6-month follow-up
Participants Population: 76 participants actively taking ART, intervention = 40, control = 36
Inclusion criteria: (1) documentation of HIV test results, (2) currently taking a recog-
nized ART regimen and (3) reporting a side effect bother in last 30 days of 8 or a bother
on the side effect and symptom distress scale
Exclusion criteria: (1) if enrolled in another behavioural coping or HIV adherence
intervention research trial or MBSR
Interventions Treatment: N = 40. Mindfulness-based stress reduction consisting of daily homework,
sitting meditation with mindfulness of breath, thoughts, and emotions, including de-
liberate awareness of routine activities such as eating and interpersonal communication,
and yoga postures
• Group size: 2 to 9.
• Facilitators: course instructor was an experienced MBSR teacher with a personal
mindfulness meditation practice who had undergone formal training in the delivery of
MBSR.
• Session duration: 2.5 to 3 hours.
• Session frequency: 8-weekly sessions plus 1 day retreat.
• Additional components: In addition to teaching mindfulness practices, the course
includes didactic presentations that include information on stress physiology and stress
reactivity. The course also addresses the effects of perception, appraisal,and attitude on
health habits and behavior and on interpersonal communication.
Control: N = 36. Waitlist control group offered the MBSR subsequent to 6 month
follow-up
Outcomes Included in the review
• Depression by BDI.
• Stress by PSS.
Not included in the review
• CD4 count.
• ART side effects by Side Effects Checklist.
• ART adherence by percentage.
Notes Setting: not reported
Country: USA
Risk of bias Risk of bias
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Duncan 2012 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Randomization was performed in
blocks of six using the SAS system’s PLAN
procedure”
Allocation concealment (selection bias) Unclear risk The trial authors did not describe any se-
lection bias.
Blinding of participants and personnel
(performance bias)
Anxiety
Unclear risk The trial authors did not describe the
method of blinding, if any
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk The trial authors did not describe the
method of blinding, if any
Incomplete outcome data (attrition bias)
All outcomes
Low risk Losses to follow-up: 7.5% intervention
group versus 5.6% control
Selective reporting (reporting bias) Low risk We did not detect any other potential
sources of selection reporting bias
Other bias Low risk No differences between groups at baseline
except for viral load and this was controlled
for
Gayner 2012
Methods Trial design: 2-arm follow-up
Follow-up: baseline, 2 months post, and 6 months follow-up
Loss to follow-up: 21 participants discontinued the intervention
Participants Population: 117 homosexual male participants, intervention =78, control = 39
Inclusion criteria: male, aged 18 to 70 years, living within 1 hour of the hospital, and
having a diagnosis of HIV
Exclusion criteria: (1) subjects with active current major depression, substance abuse,
or significant cognitive deficit
Interventions Treatment: N = 78. Mindfulness-Based Stress Reduction (MBSR): participants were
taught mindfulness skills geared towards enhancing their awareness of and relation to
current experience rather than focusing on the content and reappraisal of thoughts and
interpretations of experiences
• Group size: 14 to 18.
• Facilitators: no details given.
• Session duration: 3 hours.
• Session frequency: 8 weekly sessions.
• Addiditional components: a day-long retreat with an hour daily homework.
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Gayner 2012 (Continued)
Control:N = 39. Treatment as Usual (TAU) group offered at end of intervention
Outcomes Included in review
• Stress by Impact of Event Scale (IES).
• Anxiety by Hospital Anxiety and Depression Scale (HADS).
• Depression by HADS.
Not included in review
• Mood by Positive and Negative Affect Schedule (PANAS).
• Mindfulness by the Toronto Mindfulness Scale (TMS).
Notes Homosexual population
Ethics reviewed.
Setting: hospital
Country: Toronto, Canada
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “A randomization free-ware, soft-
ware program (Network, 1997) was uti-
lized to generate a random allocation se-
quence 2:1 in favour of the group interven-
tion for each cohort of up to 30 eligible
participants”
Allocation concealment (selection bias) Unclear risk Quote: “study staff were not aware of a
potential participant’s group member- ship
until the whole cohort was assigned at the
same time”. The trial authors did not pro-
vide any further details
Blinding of participants and personnel
(performance bias)
Anxiety
Unclear risk The trial authors did not describe the
method of blinding, if any
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk The trial authors did not describe the
method of blinding, if any
Incomplete outcome data (attrition bias)
All outcomes
High risk Losses to follow-up: 24.4% intervention
group versus 5.1% control. ITT analysis
done
Selective reporting (reporting bias) Low risk We did not detect any selective reporting
bias.
Other bias Low risk We did not detect any other sources of bias.
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Heckman 2007
Methods Trial design: 3-arm RCT
Follow-up: baseline, post, 4 months, and 8 months follow-up
Loss to follow-up: 73%; 68%, 82%
Participants Population: 299 adults, intervention = 84, control = 107
Inclusion: 18 years or older, provision of written consent, a self reported diagnosis of
HIV AIDS, and residence in a community of 50,000 people or fewer that was at least
20 miles from a city of 100,000 or more
Exclusion: there were no exclusion related to psychological functioning
Interventions Treatment: N = 108. Coping improvement group intervention used cognitive be-
havioural principles to appraise stressor severity, develop adaptive problem- and emo-
tion-focused coping skills, and optimize coping through the appropriate use of personal
and social resources
• Group size: 6 to 8.
• Facilitators: Master’s degree level in psychology or social work.
• Session duration: 90 minutes.
• Session frequency: 8 sessions.
Treatment:N=84. InformationSupportGroupprovided information onHIV symptom
management, nutrition and HIV, exercise and HIV, and discussions of personal topics
• Group size: 6 to 8 participants per group.
• Facilitators: conducted using teleconference technology and co-facilitated by
nurse practitioners or social workers.
• Session duration: 90 minutes.
• Session frequency: 8 sessions.
Control:N = 107. Usual care condition received no intervention but had access to usual
services
Outcomes Included in review
• Depression by BDI.
• Life stressors by HIV-Related Life Stressor Burden Scale (HRLSBS).
• Coping by Coping Self-Efficacy Scale.
Not included in review
• Psychological symptoms by Symptom Checklist 90-Revised (SCL-90-R).
• Emotional and social well-being by Funtional Assessment of HIV Infection
Inventory (FAHI).
• Barriers to care by Barriers to Care Scale (BACS).
• Social Support by Provision of Social Relations Scale (PSRS).
Notes Setting: telephone-delivered
Country: USA
Groups conducted separately for MSM, heterosexual men, and women
71% reporting moderate to severe depression at baseline.
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
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Heckman 2007 (Continued)
Random sequence generation (selection
bias)
Unclear risk The trial authors described the trial as “ran-
domized” but did not provide any further
details
Allocation concealment (selection bias) Unclear risk The trial authors did not describe selection
bias, if any.
Blinding of participants and personnel
(performance bias)
Anxiety
Unclear risk The trial authors did not describe the
method of blinding, if any
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk The trial authors did not describe the
method of blinding, if any
Incomplete outcome data (attrition bias)
All outcomes
High risk Losses to follow-up: 18.5 intervention
group versus 27.1% control. ITT done. A
last-observation-carried-forward (LOCF)
approach was used to input missing data
Selective reporting (reporting bias) Low risk We did not detect any selective reporting
bias.
Other bias Low risk We did not detect any other sources of bias.
Heckman 2011
Methods Trial design: 3-arm RCT
Follow-up: baseline, post, 4 months, and 8 months follow-up
Loss to follow-up: coping group 79% loss, interpersonal support group 69% loss,
individual therapy group 86% loss
Participants Population: 295 men and women over the age of 50, intervention = 104, control = 105
Inclusion: 50 years or older, a diagnosis of HIV infection or AIDS, a BDI-II score of
10 or higher, a score of 75 or more on the 3MS, a minimum value of 10 on the BDI-
II. (A minimum value of 10 on the BDI-II was used to ensure that participants had a
minimally elevated number of depressive symptoms that had the potential to be reduced
by the interventions)
Exclusion: the project did not exclude individualswith alcohol or substance use disorders,
active bipolar disorder, psychotic symptoms, or individuals receiving psychotherapy
Interventions Treatment: N = 104. Coping improvement group intervention addressed introductions
and participants’ sharing of personal histories (Session 1 and 2) appraisal and change-
ability of stressors related to one’s HIV infection and stressors related to normal ageing
(Sessions 3 and 4); developing and implementing adaptive problem- and emotion-fo-
cused coping skills (Sessions 5 through 9); optimizing coping efforts through the use of
interpersonal supports (Session 10 and 11); and termination issues and voluntary sharing
of personal contact information (Session 12)
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Heckman 2011 (Continued)
• Group size: 6 to 8 participants.
• Facilitators: Master’s degree level in psychology or social work and had provided
mental health support services to persons living with HIV AIDS for more than 10 years.
• Session duration: 90 minutes.
• Session frequency: 12 weeks.
Treatment: N = 105. Interpersonal Support Group of 12 x 90-minute group sessions (5
minutes spent on viewing and discussing videotapes on HIV-related topics of nutrition,
treatment, adherence, sexual risk reduction, 45minutes spent discussinghow the sessions’
topic pertained to their personal lives)
Facilitators: 2 Masters-level clinicians
Control: N = 86. Individual Therapy Upon Request (ITUR) Group had access to
standard psychosocial community-based services
Outcomes Included in review
• Depression by Geriatric Depression Scale (GDS).
Not included in the review
• None.
Notes Setting: community
Country: Ohio and New York, USA.
Each 90-minute group conducted separately for MSM, heterosexual men, and women
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk The trial authors described the trial as “ran-
domized” but did not provide any further
details
Allocation concealment (selection bias) Unclear risk The trial authors did not describe selection
bias, if any.
Blinding of participants and personnel
(performance bias)
Anxiety
Unclear risk The trial authors did not describe the
method of blinding, if any
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk The trial authors did not describe the
method of blinding, if any
Incomplete outcome data (attrition bias)
All outcomes
High risk Losses to follow-up: 15.4% intervention
group versus 31.4% control
Selective reporting (reporting bias) Low risk We did not detect any selective reporting
bias.
Other bias Low risk We did not detect any other sources of bias.
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Jones 2010
Methods Trial design: 2-arm RCT
Follow-up: pre, post, 12 months
Loss to follow-up: not reported.
Participants Population: 451 minority women, intervention = 212, control = 239
Inclusion: 18 years and older, meet the CDC classification for case-defined AIDS (i.
e. CD4+ cell count below 200/mm² and/or one opportunistic infection, CDC 1993),
have at least 6th grade education
Exclusion: women with psychiatric, neuropsychiatric or medical conditions were tem-
porarily excluded pending treatment
Interventions Treatment: N = 212. Cognitive Behavioural Stress Management: sessions included di-
dactic components on the physiological effects of stress, cognitive behavioural inter-
pretation of stress and emotions, identification of cognitive distortions and automatic
thoughts, rational thought replacement, coping skills training, assertiveness training,
anger management, and identification of social support
• Group size: not stated.
• Facilitators: not described.
• Session duration: 120 minutes (30 mins relaxation component and 90 mins stress
management component).
• Session frequency: 10 weekly sessions.
• Additional components: expressive support therapy addressing: needs for mutual
support, improved family and social support, emotional expressiveness, normalization
of experiences, integration of changed body image, doctor-patient relationship, and
death and dying issues
Control:N = 239. Individual 120-minute information education sessions delivered by
videotape covering stress management, relaxation, and coping with HIV. 10 sessions
Outcomes Included in this review
• Depression by BDI.
• Anxiety by STAI
• Coping Self efficacy by Cognitive Behavioral Self efficacy (CB-SE).
Not included in this review
• Socio-demographic characteristics.
Notes Setting: medical school setting and community health centres
Country: USA
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk The trial used a table of random numbers
to randomize participants to treatment
Allocation concealment (selection bias) Unclear risk The trial authors did not describe selection
bias, if any.
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Jones 2010 (Continued)
Blinding of participants and personnel
(performance bias)
Anxiety
Unclear risk The trial authors did not describe the
method of blinding, if any
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk The trial authors did not describe the
method of blinding, if any
Incomplete outcome data (attrition bias)
All outcomes
High risk Losses to follow-up: 45.1% intervention
group versus 36.9% control
Selective reporting (reporting bias) Low risk We did not detect any potential source of
selective reporting bias
Other bias Low risk We did not detect any other sources of bias.
McCain 2003
Methods Trial design: 3-arm RCT
Follow-up: pre, post, and 6 months
Loss to follow-up: 69% follow-up at 6 months
Participants Population: 148 individuals diagnosed with HIV disease (119 men, 29 women). Inter-
vention = 59, support group = 3, Waitlist = 36
Inclusion: (1) 18 years of age, (2) able to read and speak English, (3) previously aware
of their HIV diagnosis, (4) deemed capable of attending intervention sessions and com-
pleting 6 months follow-up
Exclusion: (1) no significant psychiatric illness, (2) no cognitive impairment, (3) not
pregnant or taking steroids
Interventions Treatment 1:N = 59. CBSM focused on breathing, PMR, yoga-form stretching, guided
imagery, and beginning meditation, along with cognitive restructuring techniques and
active coping skills
• Group size: 6 to 10 participants.
• Facilitators: Trial authors did not describe characteristics of the facilitators.
• Session duration: 90 minutes.
• Session frequency: 8 weekly.
Treatment 2: N = 43. SSG focused on facilitating communication related emotional
issues, problem-solving and cognitive-reframing techniques, and individual and group
empowerment
• Group size: 6 to 10 participants.
• Facilitators: facilitated by mental health nurse.
• Session duration: 90 minutes.
• Session frequency: 8 weekly.
Control:N = 36. Waitlist group
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McCain 2003 (Continued)
Outcomes Included in this review
• Stress with Mishel Uncertainity in Illness Scale (MUIS).
• Coping by Dealing with Illness Scale (DIS).
Not included in this review
• Social support by Social Provisions Scale (SPS).
• Psychological distress by Impact of Events Scale (IES).
• Overall quality of life by Functional Assessment of HIV Infection scale (FAHI).
• Neuroendocrine indicators of stress by cortisol and DHEA levels.
• Health Status by revised HIV Center Medical Staging System (rHCMSS).
• CD4 by immunophenotyping.
• NK cell cytotoxicity by cell samples.
• Cytokines levels using enzyme-linked immunosorbent assay (ELISA) kits.
• Viral load by HIV monitor assay.
Notes Setting: Trial authors did not describe the setting.
Country: USA
Separate gender groups, interaction terms included by group by gender
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “Quota sampling was used to
achieve appropriate sample representation
by gender, at a ratio of 4 males:1 female
(20%)”. The trial authors did not provide
any further details
Allocation concealment (selection bias) Unclear risk The trial authors did not describe selection
bias, if any.
Blinding of participants and personnel
(performance bias)
Anxiety
Unclear risk The trial authors did not describe the
method of blinding, if any
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk The trial authors did not describe the
method of blinding, if any
Incomplete outcome data (attrition bias)
All outcomes
High risk Losses to follow-up: 27.1% intervention
group versus 27.8% control
Selective reporting (reporting bias) Low risk We did not detect any potential source of
selective reporting bias
Other bias Low risk We did not detect any other sources of bias.
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Nakimuli-Mpungu 2015
Methods Trial design: 2-arm RCT
Follow-up: baseline, immediately post, 6 months follow-up
Loss to follow-up: 23% in intervention group, 21% lost in control group
Participants Population: 109 HIV-positive individuals (peasant farmers) with major depression,
intervention = 57, control = 52
Inclusion: 19 years or older, met the MINI International Neuropsychiatric Interview
criteria for major depression, from an urban HIV care centre, were antidepressant naive
Exclusion: individuals with severe medical disorder such as pneumonia or active tuber-
culosis, psychotic symptoms, and hearing or visual impairment
Interventions Treatment: N = 57. Group Support Psychotherapy (GSP) is a culturally sensitive inter-
vention that aims to treat depression by enhancing social support, teaching coping skills
and income generating skills
• Group size: 10 to 12 participants (gender specific groups).
• Facilitators: Mental Health workers with mental health diploma or degree, of the
same gender as group.
• Session duration: 2 to 3 hours.
• Session frequency: 8 weekly sessions.
Control: N=52. Active treatment group receives Group HIV education (GHE) imme-
diately post intervention and 6 months later
Outcomes Included in the review
• Depression by Self Reported Questionnaire (SRQ-20).
Not included in review
• Functioning levels assessed using a locally developed scale.
• Percieved social support (Multi-dimensional social support scale).
• Self Esteem (Rosenberg self esteem scale).
Notes Setting: HIV care centre, urban
Country: Uganda
Gender-specific groups
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk The trial authors performed randomization
by urn with a ratio of 1:1. The trial authors
did not provide any further details or prop-
erties of this method
Allocation concealment (selection bias) Unclear risk Men and women separately picked a pa-
per containing the intervention allocation
from a basket, ratio. The trial authors did
not provide further details on allocation
concealment
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Nakimuli-Mpungu 2015 (Continued)
Blinding of participants and personnel
(performance bias)
Anxiety
Unclear risk The trial authors did not describe the
method of blinding, if any
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk The trial authors did not describe the
method of blinding, if any
Incomplete outcome data (attrition bias)
All outcomes
High risk Losses to follow-up: 22.8% intervention
group versus 21.2% control
Selective reporting (reporting bias) Low risk We did not detect any potential source of
selective reporting bias
Other bias Low risk We did not detect any other sources of bias.
Peltzer 2012
Methods Trial design: 2 arm RCT
Follow-up: baseline, 1 month, 4 months
Loss to follow-up: 147 follow-up (96.7% follow-up); 3.9% attrition in MAI and 2.6%
attrition in SC
Participants Population: 152 HIV-positive individuals on ART with an adherence problem, inter-
vention = 76, control = 72
Inclusion: 18 years or older, new ARV medication users (2 to 24 months of ARV use)
Exclusion: Trial authors did not describe any exclusion criteria.
Interventions Treatment:N=76.Medication adherence intervention (MAI) ismedication information
combined with problem-solving skills in an experiential/interactive group format
• Group size: 10 participants.
• Facilitators: MAI led by a trained lay health worker and adherence counsellor.
• Session duration: 1 hour a month.
• Session frequency: 3 months.
Control:N= 76. Practitioner medical directive (standard of care; 20 min) led bymedical
physician. Patients individually attended monthly 1 visit to review their health status
with their medical practitioner
Outcomes Included in this review
• Depression measured by BDI-II
Not included in this review
• The Life-Windows Information-Motivation-Behavioural Skills ART adherence
questionnaire.
• CD4 count was obtained from medical chart.
Notes Setting: hospital
Country: South Africa.
Short follow-up of 3 months
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Peltzer 2012 (Continued)
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Participants were randomized into
study condition using a table of random
numbers following their baseline assess-
ment”
Allocation concealment (selection bias) Unclear risk The trial authors did not describe any se-
lection bias, if any
Blinding of participants and personnel
(performance bias)
Anxiety
Unclear risk The trial authors did not describe the
method of blinding, if any
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk The trial authors did not describe the
method of blinding, if any
Incomplete outcome data (attrition bias)
All outcomes
Low risk Losses to follow-up: 3.9% intervention
group versus 2.6% control. Trial authors
performed an intention-to-treat analysis
Selective reporting (reporting bias) Low risk We did not detect any potential source of
selective reporting bias
Other bias Low risk We did not detect any other sources of bias.
Safren 2012
Methods Trial design: 2-arm RCT
Follow-up: 3 months, 6 months and 12 months
Loss to follow-up: 84% follow-up to at least one follow-up assessment
Participants Population: 89 HIV individuals prescribed ARVS and with a history of injection drug
use, intervention = 44, control = 45
Inclusion: aged 18 to 65 years, HIV-positive, prescribed ARVs, endorsed history of
injection drug use, currently enrolled in opoid treatment for at least one month, and
met criteria for a diagnosis of current or subsyndromal depressive mood disorder
Exclusion: individuals with any active untreated or unstable major mental illness, in-
ability or unwillingness to provide informed consent, or current participation in a CBT
for depression
Interventions Treatment: N = 44. CBT-AD included Life Steps, psychoeducation about HIV and
depression, motivational interviewing for behaviour change, behavioural activation to
increase pleasurable activities, training in adaptive thinking, problem solving, PMR, and
diaphragmatic breathing
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• Group size: not stated
• Facilitators: pre- and postdoctoral clinical psychologists.
• Session duration: 50 minutes.
• Session frequency: 8 sessions over 3 months.
Control:N=45. EnhancedTreatment AsUsual (ETAU)with a letter tomedical provider
documentingparticipants depression and suggesting continued assessment and treatment
Both treatment conditions received a single-session intervention on medication adher-
ence (Life Steps) with involved 11 informational, problem-solving and cognitive-be-
havioural steps
Outcomes Included in this review
• Depression by BDI and Montgomery-Asberg Depression Rating Scale.
Not included in this review
• Clinical Global Impression - a rating of global distress and impairment for
depression and substance abuse.
• Adherence by MEMS.
• CD4.
Notes Setting: methadone clinics
Country: Boston, USA
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote “Random assignment in block of 2
- stratified by sex, depression severity and
adherence”. The trial authors did not pro-
vide any further details
Allocation concealment (selection bias) Unclear risk Quote: “Assignment to study condition
(CBT-AD or ETAU) was concealed from
both study therapists and participants until
the conclusion of the first counseling visit
(see below)”. The trial authors did not pro-
vide any further details
Blinding of participants and personnel
(performance bias)
Anxiety
Unclear risk The trial authors did not describe the
method of blinding, if any
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk An independent assessor who was blinded
to the trial conditions assessed depression
Incomplete outcome data (attrition bias)
All outcomes
High risk Losses to follow-up: 18.2% intervention
group versus 33.3% control
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Selective reporting (reporting bias) Low risk We did not detect any potential sources of
selective reporting bias
Other bias Unclear risk Small sample size of 89. CD4 count dif-
fered at baseline but controlled for in anal-
ysis
Sikkema 2013
Methods Trial design: 3-arm RCT
Follow-up: baseline, post, 4, 8, 12 months
Loss to follow-up:minimal loss to follow-up, ITT analysis done
Participants Population: 247 HIV-positive men (N = 117) and women (N = 130), intervention =
124, control = 123
Inclusion: sexual abuse as a child (age 12 and under) and/or adolescent (age 13 to 17
years); current age of 18 or older; HIV serostatus
Exclusion: acute distress due to sexual revictimization experienced within past month;
presence of impaired mental status; extreme distress or depressive symptomatology
Interventions Treatment 1: N= 124. HIV and Trauma Coping Group Intervention (LIFT) where
participants Identify stressors that they perceived to be related to their sexual abuse
experiences and those related to their HIV diagnosis, learn adaptive coping and risk
reduction skills related to both sexual abuse and HIV infection
• Group size: 6-10
• Facilitators: coping group lead by 2 clinical psychologists and 2 social workers.
Support group lead by 4 social workers.
• Session duration: 90 minutes.
• Session frequency: 15 weekly sessions.
Control: N = 123. HIV standard therapeutic support group. The comparison inter-
vention paralleled a standard therapeutic support group and was led by experienced co-
therapists not trained on the coping interventionmodel. The purpose of the group was to
provide a supportive environment for participants to address issues of HIV and trauma
Outcomes Included in this review
• Traumatic Stress by the Impact of Events Scale (IES).
• Avoidant coping by the Coping with AIDS ScaleWays of Coping Questionnaire
(WOCQ).
Not included in this review
• Condom use by frequency of unprotected vaginal and anal intercourse with all
partners in last month.
Notes Setting: Community Health Centre
Country: USA
Different populations in each report
Risk of bias Risk of bias
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Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk The trial authors described the trial as ’ran-
domized’ but did not provide any further
details
Allocation concealment (selection bias) Unclear risk The trial authors did not describe the
method of allocation concealment, if any
Blinding of participants and personnel
(performance bias)
Anxiety
Unclear risk The trial authors did not describe the
method of blinding, if any
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk The trial authors did not describe the
method of blinding, if any
Incomplete outcome data (attrition bias)
All outcomes
High risk Losses to follow-up: 16.5% Intervention
group versus 33.3% control. The trial au-
thors conducted an intention-to-treat anal-
ysis
Selective reporting (reporting bias) Low risk We did not detect any other sources of se-
lective reporting bias
Other bias Low risk We did not detect any other potential
sources of bias.
Abbreviations: HAART: highly active antiretroviral therapy; PMR: progressive muscle relaxation; RCT: randomized controlled trial.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Antoni 2000 No 3-month follow-up post intervention.
Balfour 2006 Individual psychoeducational intervention, not a group intervention
Bormann 2009 No specified outcomes reported. The study measured salivary cortisol as a biomarker of immune function
Carrico 2009 Individual counselling sessions, not a group intervention.
Chan 2005 No 3-month follow-up postintervention.
50Psychosocial group interventions to improve psychological well-being in adults living with HIV (Review)
Copyright © 2017 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
(Continued)
Chhatre 2013 Not a group-based intervention.
Chiou 2004 No specified outcomes measured.
Creswell 2009 No 3-month follow-up postintervention.
Cruess 2000 No 3-month follow-up postintervention.
Côté 2002 Nurse-patient intervention, not a group intervention.
Davies 2006 Overview of intervention, not a randomized controlled trial (RCT)
Davies 2009 Only formative qualitative data presented, not a RCT.
Evans 2003 We contacted the study author. This was not a group intervention
Fife 2008 Individual therapy for patient-partner dyads. This was not a group intervention
Gifford 1998 No 3-month follow-up postintervention, only 3-month follow-up after baseline
Golin 2006 Individual, not a group intervention.
Goodkin 1998 No specified outcomes.
Goodkin 1999 No 3-month postintervention follow-up.
Hansen 2009 No specified outcomes included.
Heckman 2004 No RCT result reported, only baseline data reported.
Heckman 2006 No post 3-month follow-up.
Ingersoll 2011 Not a group intervention.
Jensen 2013 Measured positive affect and positive mood. These are not specified outcomes
Jones 2005 Not a RCT as no control group.
Kaaya 2013 No 3-month follow-up postintervention.
Kalichman 2005 Describes intervention development and components, not a RCT
Koenig 2008 Nurse-patient intervention, not a group intervention.
Kunutsor 2011 Treatment supporter intervention, not a group intervention.
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Laperriere 2005 The study author presented a subgroup analysis only, a subgroup from the larger Jones 2010 study.
Latkin 2003 Not a HIV-positive population.
Lechner 2003 No 3-month follow-up postintervention.
Lee 1999 Not a RCT and no control group.
Lehavot 2011 Not a group intervention.
MacNeil 1999 Not a group intervention.
Marhefka 2014 No specified outcomes reported.
Markowitz 1998 Interpersonal therapy, not a group intervention.
Molassiotis 2002 Not truly randomized.
Mundell 2011 Not a RCT, quasi-experimental.
Nakimuli-Mpungu 2014 No 3-month follow-up postintervention.
Nokes 2003 No RCT reported.
Olley 2006 Individual therapy, not a group intervention.
Pacella 2012 Not a group intervention.
Papas 2011 No specified outcomes reported.
Petersen 2014 No 3-month follow-up postintervention.
Prado 2012 Adolescents 12 to 17 years old.
Proeschold-Bell 2011 No RCT reported.
Rao 2009 Individual art therapy sessions, not a group intervention.
Rao 2012 No RCT reported.
Ravaei 2013 No 3-month follow-up postintervention, small sample size (N = 30), and unsure whether a group inter-
vention
Remien 2005 Not a group intervention. The intervention was individually administered to each couple
Robins 2006 No 3-months follow-up postintervention.
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Roth 2012 One-to-one intervention by lay health workers, not a group intervention
Rotheram-Borus 2011 Study protocol only. No RCT data reported.
Rotheram-Borus 2012 No specified outcomes.
Sacks 2011 Both individual and group formats to intervention. No effects reported for group components of inter-
vention
Safren 2009 Control invited to cross over to intervention at 3-months postintervention. No postintervention follow-
up of 3 months for control group
Saleh-Onoya 2009 Measured coping using 3 subscales of Coping Scale.
SeyedAlinaghi 2012 No specified outcomes. Used global score of broad range of psychological symptoms, did not measure
depression and anxiety outcomes separately
Sikkema 2004 No 3-month follow-up postintervention.
Simoni 2013 Not a group-based intervention.
Stewart 2001 Content analysis, no RCT reported.
Szapocznik 2004 Therapy sessions with family at home.
Wagner 2006 Individually administered intervention, not a group intervention
Williams 2014 Not a group intervention but home-based individual intervention
Wingood 2004 Inconsistencies in reporting of data.
Wong 2008 Individual counselling sessions, not a group intervention.
Wyatt 2004 There was unclear presentation of follow-up data and it was unclear whether it was 3-month or 6-month
follow-up data. We contacted the study author but received no response
Yu 2014 Not a RCT, no control group, HIV-positive and HIV-negative mixed sample
Zisook 1998 Individual psychotherapy, not a group intervention.
Znoj 2010 Not a group intervention.
Abbreviations: RCT: randomized controlled trial.
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D A T A A N D A N A L Y S E S
Comparison 1. Group therapy (CBT) versus control
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Depression scores 10 Std. Mean Difference (IV, Random, 95% CI) Subtotals only
1.1 Baseline mean scores 10 1600 Std. Mean Difference (IV, Random, 95% CI) 0.05 [-0.05, 0.15]
1.2 Mean score at end of
group sessions (10 to 12 weeks
after randomization)
9 1142 Std. Mean Difference (IV, Random, 95% CI) -0.17 [-0.29, -0.05]
1.3 Mean score at longest
follow-up (6 to 15 months after
randomization)
10 1139 Std. Mean Difference (IV, Random, 95% CI) -0.26 [-0.42, -0.10]
2 Depression scores at longest
follow-up; subgrouped by
depression score used
10 Mean Difference (IV, Random, 95% CI) Subtotals only
2.1 Beck depression inventory
(score out of 63)
6 753 Mean Difference (IV, Random, 95% CI) -1.41 [-2.61, -0.21]
2.2 Hospital Anxiety and
Depression score (score out of
21)
1 71 Mean Difference (IV, Random, 95% CI) -2.12 [-3.90, -0.34]
2.3 Geriatric depression score
(score out of 30)
1 160 Mean Difference (IV, Random, 95% CI) -1.48 [-2.83, -0.13]
2.4Centre for Epidemiological
Studies (score out of 60)
1 70 Mean Difference (IV, Random, 95% CI) 0.30 [-4.03, 4.63]
2.5 Self-reported
questionnaire (score out of 20)
1 85 Mean Difference (IV, Random, 95% CI) -2.5 [-3.91, -1.09]
2.6 Profile of mood states
(depression) (score out of 60)
1 101 Mean Difference (IV, Random, 95% CI) -4.30 [-10.47, 1.87]
2.7 Montgomery-Asberg
Depression Rating Scale (score
out of 60)
1 66 Mean Difference (IV, Random, 95% CI) -4.72 [-9.67, 0.23]
3 Depression scores (trials with
mean scores in the range of
depression at baseline)
5 Std. Mean Difference (IV, Random, 95% CI) Subtotals only
3.1 Baseline mean scores 5 790 Std. Mean Difference (IV, Random, 95% CI) 0.04 [-0.10, 0.18]
3.2 Mean score at longest
follow-up
5 628 Std. Mean Difference (IV, Random, 95% CI) -0.20 [-0.46, 0.06]
4 Depression scores at longest
follow-up; subgrouped by
control
10 Std. Mean Difference (IV, Random, 95% CI) Subtotals only
4.1 Standard care ± a minimal
intervention (< 1 day)
6 595 Std. Mean Difference (IV, Random, 95% CI) -0.24 [-0.45, -0.04]
4.2 Alternative group sessions 3 300 Std. Mean Difference (IV, Random, 95% CI) -0.25 [-0.71, 0.22]
4.3 Individual therapy 2 389 Std. Mean Difference (IV, Random, 95% CI) -0.22 [-0.42, -0.01]
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5 Depression scores (trials with
mean scores in the normal
range at baseline)
5 Std. Mean Difference (IV, Random, 95% CI) Subtotals only
5.1 Baseline mean scores 5 810 Std. Mean Difference (IV, Random, 95% CI) 0.10 [-0.11, 0.30]
5.2 Mean score at longest
follow-up (6 to 15 months after
randomization)
5 511 Std. Mean Difference (IV, Random, 95% CI) -0.30 [-0.48, -0.13]
6 Depression scores at longest
follow-up; subgrouped by
primary focus of intervention
10 Std. Mean Difference (IV, Random, 95% CI) Subtotals only
6.1 Stress management 3 216 Std. Mean Difference (IV, Random, 95% CI) -0.46 [-0.73, -0.18]
6.2 Coping 3 396 Std. Mean Difference (IV, Random, 95% CI) -0.14 [-0.37, 0.08]
6.3 Self-efficacy 1 229 Std. Mean Difference (IV, Random, 95% CI) -0.13 [-0.39, 0.13]
6.4 Depression 1 85 Std. Mean Difference (IV, Random, 95% CI) -0.75 [-1.19, -0.30]
6.5 Adherence and depression 1 66 Std. Mean Difference (IV, Random, 95% CI) -0.43 [-0.92, 0.06]
6.6 Adherence 1 147 Std. Mean Difference (IV, Random, 95% CI) 0.03 [-0.30, 0.35]
7 Depression scores at longest
follow-up; subgrouped by
gender
10 1139 Std. Mean Difference (IV, Random, 95% CI) -0.26 [-0.42, -0.10]
7.1 Men only 3 215 Std. Mean Difference (IV, Random, 95% CI) -0.26 [-0.55, 0.04]
7.2 Women only 1 229 Std. Mean Difference (IV, Random, 95% CI) -0.13 [-0.39, 0.13]
7.3 Both men and women 6 695 Std. Mean Difference (IV, Random, 95% CI) -0.31 [-0.55, -0.07]
8 Anxiety scores 4 Std. Mean Difference (IV, Random, 95% CI) Subtotals only
8.1 Baseline mean scores 4 697 Std. Mean Difference (IV, Random, 95% CI) 0.11 [-0.05, 0.27]
8.2 Mean score at end of
group sessions (10 to 12 weeks
after randomization)
3 420 Std. Mean Difference (IV, Random, 95% CI) -0.01 [-0.25, 0.22]
8.3 Mean score at longest
follow-up (12 to 15 months
after randomization)
4 471 Std. Mean Difference (IV, Random, 95% CI) -0.12 [-0.31, 0.06]
9 Anxiety scores: at longest follow-
up; subgrouped by anxiety scale
used
4 Mean Difference (IV, Random, 95% CI) Subtotals only
9.1 State trait anxiety
inventory (score between 20
and 80)
1 70 Mean Difference (IV, Random, 95% CI) -0.80 [-6.06, 4.46]
9.2 Modified State Trait
Anxiety Inventory (score
between 10 and 40)
1 229 Mean Difference (IV, Random, 95% CI) -0.61 [-2.09, 0.87]
9.3 Hospital Anxety and
Depression Scale (score out of
21)
1 71 Mean Difference (IV, Random, 95% CI) -2.4 [-4.92, 0.12]
9.4 Profile of Mood States
(score out of 36)
1 101 Mean Difference (IV, Random, 95% CI) 0.20 [-2.64, 3.04]
10 Anxiety scores: at longest
follow-up; subgrouped by
control
4 Mean Difference (IV, Random, 95% CI) Subtotals only
10.1 Standard care ± a
minimal intervention (< 1 day)
2 172 Mean Difference (IV, Random, 95% CI) -1.18 [-3.73, 1.36]
10.2 Alternative group
therapy
1 70 Mean Difference (IV, Random, 95% CI) -0.80 [-6.06, 4.46]
10.3 Individual therapy 1 229 Mean Difference (IV, Random, 95% CI) -0.61 [-2.09, 0.87]
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11 Stress scores 5 Std. Mean Difference (IV, Random, 95% CI) Subtotals only
11.1 Baseline mean scores 5 695 Std. Mean Difference (IV, Random, 95% CI) 0.12 [-0.03, 0.27]
11.2 Mean score at end of
group sessions
4 533 Std. Mean Difference (IV, Random, 95% CI) -0.06 [-0.23, 0.12]
11.3 Mean score at longest
follow-up
5 507 Std. Mean Difference (IV, Random, 95% CI) -0.04 [-0.23, 0.15]
12 Stress scores at longest follow-
up; subgrouped by stress score
used
5 Mean Difference (IV, Random, 95% CI) Subtotals only
12.1 Perceived stress score
(score out of 40)
1 70 Mean Difference (IV, Random, 95% CI) -0.70 [-3.77, 2.37]
12.2 Dealing with illness scale 1 69 Mean Difference (IV, Random, 95% CI) -1.80 [-7.62, 4.02]
12.3 HIV-related life-stressor
burden score (score out of 5)
1 166 Mean Difference (IV, Random, 95% CI) 0.08 [-0.06, 0.22]
12.4 Life experiences survey
(score out of 3)
1 39 Mean Difference (IV, Random, 95% CI) -1.36 [-3.00, 0.28]
12.5 Impact of event scale
(score out of 75)
2 232 Mean Difference (IV, Random, 95% CI) -1.33 [-3.60, 0.95]
13 Stress scores at longest follow-
up; subgrouped by control
5 Mean Difference (IV, Random, 95% CI) Subtotals only
13.1 Standard care ± a
minimal intervention (< 1 day)
3 274 Mean Difference (IV, Random, 95% CI) -0.37 [-1.46, 0.71]
13.2 Alternative group
therapy
4 454 Mean Difference (IV, Random, 95% CI) 0.09 [-0.05, 0.22]
13.3 Individual therapy 0 0 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
14 Coping scores 5 Std. Mean Difference (IV, Random, 95% CI) Subtotals only
14.1 Baseline mean scores 5 1022 Std. Mean Difference (IV, Random, 95% CI) 0.01 [-0.11, 0.14]
14.2 Mean score at end of
group sessions
5 762 Std. Mean Difference (IV, Random, 95% CI) 0.02 [-0.16, 0.19]
14.3 Mean score at longest
follow-up (6 months after
randomization)
5 697 Std. Mean Difference (IV, Random, 95% CI) 0.04 [-0.11, 0.19]
15 Coping scores at longest follow-
up; subgrouped by coping score
used
5 Mean Difference (IV, Random, 95% CI) Subtotals only
15.1 Dealing with illness:
coping subscale (score out of
120)
1 69 Mean Difference (IV, Random, 95% CI) 1.90 [-1.79, 5.59]
15.2 Cognitive behavioural
self-efficacy scale (score out of
28)
1 229 Mean Difference (IV, Random, 95% CI) -0.16 [-1.29, 0.97]
15.3 Coping self-efficacy scale
(score out of 260)
2 236 Mean Difference (IV, Random, 95% CI) 1.76 [-6.53, 10.05]
15.4 Avoidant coping scale
(score out of 69)
1 163 Mean Difference (IV, Random, 95% CI) -1.70 [-5.26, 1.86]
16 Coping scores at longest follow-
up; subgrouped by control
5 Mean Difference (IV, Random, 95% CI) Subtotals only
16.1 Standard care ± a
minimal intervention (< 1 day)
2 235 Mean Difference (IV, Random, 95% CI) 0.19 [-0.21, 0.59]
16.2 Alternative group
therapy
4 454 Mean Difference (IV, Random, 95% CI) -0.25 [-0.67, 0.17]
56Psychosocial group interventions to improve psychological well-being in adults living with HIV (Review)
Copyright © 2017 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
16.3 Individual therapy 1 229 Mean Difference (IV, Random, 95% CI) -0.16 [-1.29, 0.97]
Comparison 2. Group therapy (mindfulness) versus control
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Depression scores 3 Std. Mean Difference (IV, Random, 95% CI) Subtotals only
1.1 Baseline mean scores 3 286 Std. Mean Difference (IV, Random, 95% CI) -0.11 [-0.35, 0.12]
1.2 Mean scores at end of
group sessions (8 weeks after
randomization)
3 242 Std. Mean Difference (IV, Random, 95% CI) -0.22 [-0.48, 0.04]
1.3 Mean score at longest
follow-up
3 233 Std. Mean Difference (IV, Random, 95% CI) -0.23 [-0.49, 0.03]
2 Anxiety scores 2 Std. Mean Difference (IV, Random, 95% CI) Subtotals only
2.1 Baseline mean scores 2 210 Std. Mean Difference (IV, Random, 95% CI) -0.01 [-0.29, 0.27]
2.2 Mean scores at end of
group sessions (8 weeks after
randomization)
2 178 Std. Mean Difference (IV, Random, 95% CI) -0.23 [-0.53, 0.07]
2.3 Mean score at longest
follow-up
2 162 Std. Mean Difference (IV, Random, 95% CI) -0.16 [-0.47, 0.15]
3 Stress scores 2 Mean Difference (IV, Random, 95% CI) Subtotals only
3.1 Baseline mean scores 2 169 Mean Difference (IV, Random, 95% CI) -1.02 [-3.50, 1.46]
3.2 Mean scores at end of
treatment
2 139 Mean Difference (IV, Random, 95% CI) -2.29 [-4.46, -0.11]
3.3 Mean score at longest
follow-up
2 137 Mean Difference (IV, Random, 95% CI) -2.02 [-4.23, 0.19]
A D D I T I O N A L T A B L E S
Table 1. Description of populations
Trial Country Age (years) On antiretroviral
therapy (ART)
General popula-
tion or subgroup
Mood disorders
Inclusion criteria Exclusion criteria
Antoni 2006 USA 18 to 65 Yes Homosexual men None stated Current psychosis
or panic disorder
Antoni 2008 USA 18 to 60 Not stated Women with evi-
dence of CIN1
None stated Current major
psychiatric illness
Berger 2008 Switzerland 18 to 65 Yes General
population
None stated Current ma-
jor psychiatric dis-
order
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Table 1. Description of populations (Continued)
Carrico 2005 USA Not stated No (recruited
largely during the
era prior to highly
active an-
tiretroviral therapy
(HAART; 1992 to
1997)
Homosexual men None stated Current major
psychiatric illness
Jones 2010 USA > 18 Not stated Minority women None stated Untreated major
psychiatric illness
McCain 2003 USA > 18 Yes General
population
None stated Significant psychi-
atric illness
Safren 2012 USA 18 to 65 Yes Prior intravenous
drug users
Current depressive
mood disorder
Untreated or un-
stable major men-
tal illness
Heckman 2007 USA Not stated Not stated Rural population No inclusion or
exclusion criteria
related to psycho-
logical function-
ing were employed
No inclusion or
exclusion criteria
related to psycho-
logical function-
ing were employed
Heckman 2011 USA > 50 Not stated Individuals over
the age of 50
BDI-II score is
minimum 10
Exclude severe de-
pression or cogni-
tive impairment
Sikkema 2013 USA Not stated Not stated History of child
sexual abuse
Not stated Not stated
Peltzer 2012 South Africa > 18 Yes Individ-
uals with ART ad-
herence problem/
new antiretroviral
(ARV) medication
users (6 to 24
months of ARV
use)
Not stated Not stated
Chesney 2003 USA 21 to 60 No Homosexual men Reported de-
pressed mood 10
or higher on CES-
D scale
Ma-
jor depressive dis-
order or other psy-
chotic disorders
Bormann 2006 USA 18 to 65 Not stated Adult men and
women (50% ho-
mosexual)
Not stated Cognitive impair-
ment of active psy-
chosis
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Table 1. Description of populations (Continued)
Duncan 2012 USA Not specified Yes Adult men and
women who re-
ported
distress associated
with side effects
from ART treat-
ment
Reporting a level
of side effect-re-
lated bother for
the previous 30
days at or above
eight (correspond-
ing to the 40th
percentile in an-
other sample) on
the side effect and
symptom distress
scale
Severe cognitive
impairment,
active psychosis,
or active substance
abuse
Gayner 2012 Canada Not specified Not stated Homosexual men None stated Active current ma-
jor depression,
substance abuse,
or significant cog-
nitive deficit
Nakimuli-
Mpungu 2015
Uganda > 19 Not stated Both men and
women
People with major
depres-
sion on Mini Psy-
chiatric Interview
Scale
The trial excluded
individuals with a
severe medical dis-
or-
der such as pneu-
monia or active
tuberculosis, psy-
chotic symptoms,
and hearing or vi-
sual impairment
Abbreviations: ART: antiretroviral therapy; ARV: antiretroviral.
Table 2. Depression scales reported by trials
Scale Number of
items
(depression)
Scale for each
item1
Total score
(depression)
Interpretation Description2 Trials
Beck Depression
Inventory
(BDI/BDI-II) (
Beck 1988)
21 0 (I do not) to 3
(I do and I can’t
stand it)
0 to 63 0 to 13: minimal
14 to 19: mild
20 to 28: moder-
ate
29 to 63: severe
Participants rate
the inten-
sity of depressive
feelings over the
preceding 1 or 2
weeks
Carrico 2005;
Antoni 2006;
Heckman 2007;
Jones 2010;
Duncan 2012;
Peltzer 2012;
Safren 2012
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Table 2. Depression scales reported by trials (Continued)
Hospital Anxiety
and Depression
Scale (HADS) (
Zigmond 1983)
7 0 (not at all) to 3
(very often)
0 to 21 0 to 7: normal
8 to 10: border-
line
11 to 21: depres-
sion
Participants rate
the frequency of
depressive
thoughts and be-
haviours over the
preceding 4
weeks
Berger 2008;
Gayner 2012
Geriatric
Depression Scale
(GDS) (Yesavage
1982)
30 0 (no) to 1 (yes) 0 to 30 0 to 9: normal
10 to 19: mild
20 to 30: severe
Participants re-
port the presence
or absence of de-
pressive
thoughts and be-
haviours
Heckman 2011
The Cen-
tre for Epidemi-
ological Studies-
Depression Scale
(CES-D)
(Radloff 1977)
20 0 (not at all) to 3
(all of the time)
0 to 60 0 to 15: normal
16 to 60: depres-
sion
Cut off is 16
Participants rate
the frequency of
depressive symp-
toms,
feelings, and be-
haviours over the
past week
Chesney 2003;
Bormann 2006
Self
Reported Ques-
tionnaire (SRQ-
20)
(Sheehan 1997)
20 0 (no) to 1 (yes) 0 to 20 0 to 5: normal
6 to 20: depres-
sion
Participants re-
port the presence
or absence of
depressive symp-
toms, thoughts,
and behaviours
Nakimuli-
Mpungu 2015
Profile of Mood
States (POMS)
Depression (D)
(McNair 1971)
15 0 (not at all) to 4
(extremely)
0 to 60 Higher scores in-
dicate worsening
depression
Participants rate
adjectives
describing their
mood states over
the past week
Antoni 20063
Montgomery-
Asberg De-
pression Rating
Scale (MADRS)
(Montgomery
1979)
10 0 (normal) to 6
(severe)
0 to 60 0 to 6: normal
7 to 19: mild
20 to 34: moder-
ate
> 34: severe
A
physician assess-
ment based on a
clinical interview
covering depres-
sion symptoms
Safren 20123
1The exact responses may vary between items.
2The descriptions in this table represent our best understanding of the scale derived from the description provided by the included
studies and other information available through Internet searches. The exact scale used in the trials may have differed.
3These papers presented more than one measure of depression. In the main analysis only Beck Depression Inventory was presented.
The additional measures are presented in Analysis 1.2 and had similar findings.
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Table 3. Anxiety scales reported by the included trials
Scale Number of
items (anxiety)
Score for each
item1
Total score
(anxiety)
Interpretation Description2 Trials
Profile of Mood
States
(POMS) Anxi-
ety (A)
(McNair 1971)
9 0 (not at all) to 4
(extremely)
0 to 36 Higher scores in-
dicate worsening
anxiety
Participants rate
adjectives
describing their
mood states over
the past week
Antoni 2006
Hospital Anxiety
and Depression
Scale (HADS) (
Zigmond 1983)
7 0 (not at all) to 3
(very often)
0 to 21 0 to 7: normal
8 to 10: border-
line
11 to 21: anxiety
Participants rate
the frequency of
anxiety feelings
and behaviours
over the preced-
ing 4 weeks
Berger 2008;
Gayner 2012
State Trait-Anxi-
ety Inventory
(STAI)
(Spielberger
2010)
20 1 (not at all) to 4
(very much so)
20 to 80 A cut point of 39
to
40 has been sug-
gested to detect
clinically signifi-
cant symptoms
Partici-
pants rate the fre-
quency and in-
tensity of anxiety
feelings at this
moment (state),
and more gener-
ally (trait)
Chesney 2003;
Bormann 2006;
Jones 2010
1The exact responses may vary between items.
2The descriptions in this table represent our best understanding of the scale derived from the description provided by the included
studies and other information available through Internet searches. The exact scale used in the trials may have differed.
Table 4. Stress scales reported by trials
Scale Number of
items
Score for each
item1
Total score Interpretation Description2 Trials
Perceived Stress
Scale (PSS)
(Cohen 1983)
10 0 (never) to 4
(very often)
0 to 40 Higher scores in-
dicate higher per-
ceived stress
Partic-
ipants rate the fre-
quency of stress re-
lated thoughts and
feelings in the pre-
ceding 4 weeks
Chesney 2003;
Bormann 2006;
Duncan 2012
Dealing with Ill-
ness Scale - Stress
subscale (DIS) (
McCain 1992)
Unclear Unclear Unclear Higher scores re-
flect higher stress
Participants rate
the desirability or
undesirability and
personal impact of
experienced events
McCain 2003
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Table 4. Stress scales reported by trials (Continued)
HIV-Related
Life-Stress Scale
(Sikkema 2000)
19 1 (not a prob-
lem) to 5 (most
serious problem)
1 to 5 Higher scores in-
dicate higher stress
Participants
rate the severity of
each HIV-related
potential stressor
Heckman 2007
Life Experiences
Survey (LES) (
Sarason 1978)
10 0 (not at all
stressed) to 3 (ex-
tremely stressful)
0 to 3 0 = not at all
stressed
1 = mildly stressed
2 = moderately
stressed
3 = extremely
stressed
Participants
rate the extent to
which an event
commonly expe-
rienced by HIV-
positive women
had been stressful
Antoni 2008 (a
10-item abbrevi-
ated version)
Impact of Event
Scale (IES)
(Horowitz 1979)
15 0 (not at all) to 4
(often)
0 to 75 Higher scores in-
dicate higher im-
pact
Par-
ticipants rate the
frequency of in-
trusive or avoidant
thoughts and ex-
periences over the
preceding 7
to 28 days (the au-
thors describe this
scale as measuring
’psychological dis-
tress’ or ’traumatic
stress’)
McCain 2003;
Gayner 2012;
Sikkema 2013
1The exact responses may vary between items.
2The descriptions in this table represent our best understanding of the scale derived from the description provided by the included
studies and other information available through Internet searches. The exact scale used in the trials may have differed.
Table 5. Description of cognitive-behavioural interventions
Trial Group
size
Session
duration
(mins)
Ses-
sion fre-
quency
Intervention Compar-
ison
Underly-
ing the-
ory
Primary
focus
Components
Skills
training
Relax-
ation
tech-
niques
Peer sup-
port2
Educa-
tion2
McCain
2003
6 to 10 90 Weekly
for 8
weeks
Cogni-
tive-be-
havioural
Stress
manage-
ment
Cognitive
restruc-
turing
coping
Progres-
sive mus-
cle relax-
ation
Not
described
Not
described
No inter-
vention -
waitlist
group
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Table 5. Description of cognitive-behavioural interventions (Continued)
skills (PMR)/
medita-
tion/yoga
Carrico
2005
4 to 9 135 Weekly
for 10
weeks
Cogni-
tive-be-
havioural
Stress
manage-
ment
Cog-
nitive re-
structur-
ing, cop-
ing skills,
anger
manage-
ment, use
of social
network
PMR/
medita-
tion
Not
described
Not
described
No inter-
vention -
waitlist
group
Antoni
2006
4 to 9 135 Weekly
for 10
weeks
Cogni-
tive-be-
havioural
Stress
manage-
ment
Cog-
nitive re-
structur-
ing, cop-
ing skills
PMR/
medita-
tion
Not
described
Medi-
cation ad-
herence
1 hour
medi-
cation ad-
herence
training
(MAT)
Antoni
2008
4 to 6 135 Weekly
for 10
weeks
Cogni-
tive-be-
havioural
Stress
manage-
ment
Cog-
nitive re-
structur-
ing, cop-
ing skills,
assertive-
ness,
anger
manage-
ment, use
of social
network
PMR/
medita-
tion
Not
described
Not
described
Con-
densed 1
day
CBSM
workshop
Berger
2008
4 to 10 120 Weekly
for 12
weeks
Cogni-
tive-be-
havioural
Stress
manage-
ment
Cognitive
strategies
PMR Group
dynamic
exercises
HIV re-
lated top-
ics
No inter-
ven-
tion - 30-
minute
health
check by
physician
Sikkema
2013
10 90 Weekly
for 15
weeks
Cognitive
theory of
stress and
coping
Trau-
matic
stress
Cognitive
appraisal,
coping
skills
’relax-
ation
strategies’
Not
described
Not
described
Atten-
tion con-
trol -HIV
stan-
dard ther-
apeutic
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Table 5. Description of cognitive-behavioural interventions (Continued)
support
group
Chesney
2003
8 to 10 90 Weekly
for 10
weeks
Cognitive
theory of
stress and
coping
Coping/
stress
Apprais-
ing stres-
sors, cop-
ing skills,
stress
manage-
ment
’relax-
ation
guidance’
Skill
build-
ing group
exercises
Psychoe-
ducation
around
models of
coping
No inter-
vention -
waitlist
group
Heckman
2007
6 to 8 90 Weekly
for 8
weeks
Transac-
tional
model of
stress and
coping
Coping Apprais-
ing stres-
sors, cop-
ing skills,
use of
personal
and social
resources
No Not
described
Not
described
No inter-
vention -
usual care
Heckman
2011
6 to 810 90 Weekly
for 12
weeks
Transac-
tional
model of
stress and
coping
Coping Apprais-
ing stres-
sors, cop-
ing skills,
use of
personal
and social
resources
No Not
described
Not
described
No inter-
vention
- individ-
ual ther-
apy upon
request
(ITUR)
Jones
2010
Not
stated
120 Weekly
for 10
weeks
Cogni-
tive-be-
havioural
Self-
efficacy
Cog-
nitive re-
structur-
ing, stress
manage-
ment,
cop-
ing skills,
anger
manage-
ment, use
of social
network
’relax-
ation’
Expres-
sive sup-
portive
therapy
HIV/
men-
tal health
topics
Atten-
tion con-
trol group
Nakimuli-
Mpungu
2015
10 to 12 120 to
180
Weekly
for 8
weeks
Cogni-
tive-be-
havioural,
social
learning
theory,
Depres-
sion
Cop-
ing skills,
prob-
lem solv-
ing skills,
deal-
Not
described
Group
rituals
Triggers,
symp-
toms, and
treatment
of depres-
sion.
Ac-
tive con-
trol group
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Table 5. Description of cognitive-behavioural interventions (Continued)
and the
sustain-
able
liveli-
hoods
frame-
work
ing with
stigma,
income-
genera-
tion
Safren
2012
Not
stated
50 mins Weekly
for 9
weeks
Cogni-
tive-be-
havioural
Adher-
ence/ de-
pression
Cog-
nitive re-
structur-
ing, prob-
lem solv-
ing, activ-
ity
schedul-
ing
PMR/
diaphrag-
matic
breathing
Not
described
Adher-
ence, de-
pression
En-
hanced
treatment
as usual
(ETAU)
Peltzer
2012
10 60 mins Monthly
for 3
months
Cogni-
tive-be-
havioural
Adher-
ence
Not
specif-
ically de-
scribed
Not
described
Buddy
sys-
tem to in-
crease so-
cial sup-
port
Knowl-
edge of
HIV
and HIV-
related
medica-
tion
No inter-
vention
- standard
care
Abbreviations: HIV: human immunodeficiency virus; PMR: progressive muscle relaxation.
1The interventions used in McCain 2003, Carrico 2005, Antoni 2006, Antoni 2008, Berger 2008, and Jones 2010 appear to be very
similar.
2Although peer support and education were often not well described in these papers, these aspects are inevitable with group therapy
and are likely to be an important factor in any observed effect regardless of the therapeutic theory.
Table 6. Coping scales reported by trials
Scale Number of
items
Score for each
item1
Total score Interpretation Description2 Trials
Cop-
ing Self-Efficacy
Scale (CSES) (
Chesney 2006)
26 0 (cannot do at
all) to 10 (certain
can do)
0 to 260 Higher scores in-
dicate better cop-
ing skills
Partic-
ipants rate the ex-
tent to which they
believe they could
perform
behaviours impor-
tant to adaptive
coping
Chesney 2003;
Heckman 2007
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Table 6. Coping scales reported by trials (Continued)
Cognitive Be-
havioral Self Ef-
ficacy (CB-SE) (
Ironson 1987)
7 0 (not at all) to 4
(all of the time)
0 to 28 Higher scores in-
dicate higher self-
efficacy
Par-
ticipants rate their
certainty that they
could perform cer-
tain skills related
to AIDS, and an-
tiretroviral medi-
cation adherence
Jones 2010
Dealing
with Illness Scale
- coping subscale
(DIS) (McCain
1992)
40 0 (never used)
to 3 (regularly
used)
0 to 120 Higher scores re-
flect
more frequent use
of the various cop-
ing strategies
The DIS is a 40-
item coping sub-
scale modelled on
the Revised Ways
of Coping Check-
list. Participants
rate the frequency
that thoughts
or behaviours have
been used to deal
with problems and
stresses over the
past month
McCain 2003
’Avoidant Cop-
ing Scale’
Created from 23
items taken from
’The ways
of Coping Ques-
tionnaire’
and ’the Coping
with AIDS Scale’
(Sikkema 2013)
23 0 (not at all) to
3 (used a great
deal)
0 to 69 Higher scores re-
flect more fre-
quent use of cop-
ing strategies
Partici-
pants rate how of-
ten they have used
avoidant strategies
for coping
Sikkema 2013
1The exact responses may vary between items.
2The descriptions in this table represent our best understanding of the scale derived from the description provided by the included
studies and other information available through Internet searches. The exact scale used in the trials may have differed.
Table 7. Description of mindfulness interventions
Trial Group size Session du-
ration
(mins)
Session fre-
quency
Intervention Compari-
son
Primary fo-
cus
Secondary components
Relaxation
techniques
Peer
support
Education
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Table 7. Description of mindfulness interventions (Continued)
Duncan
2012
Not stated 150 to 180 Weekly for 8
weeks plus 1
day retreat
Mindful-
ness-stress
reduction
Mindfulness
meditation
Not
described
Stress physi-
ology and re-
activity
No
interven-
tion - wait-
list group
Gayner
2012
14 to 18 180 Weekly for 8
weeks plus 1
day retreat
Mindful-
ness-stress
reduction
Mindfulness
meditation
Not
described
Not
described
No in-
tervention -
treatment as
usual (TAU)
group of-
fered at end
of interven-
tion
Bormann
2006
8 to 15 90 Weekly for 5
weeks, then
4 automated
phone
calls, then a
final session
in week 10
Mindful-
ness-stress
reduction
Mantram
repetition
Not
described
Not
described
Attention
control
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